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GENERAL INTRODUCTION 
Glutathione (GSH), a tripeptide molecule (Y-Glu-Cys-Gly), is widely 
distributed in animal tissues, plants, and microorganisms. In animals, it is 
present in amounts ranging from 0.5 to 10 mM (1) and is thus the most 
important cellular non-protein thiol. In many cells, it accounts for more than 
90% of the total non-protein sulfhydryl compounds (2). 
Glutathione participates in numerous and diverse cellular processes (1,3). 
It protects cells from the toxic effects of many reactive oxygen compounds as 
a substrate in the removal of intermediates such as hydrogen peroxide and 
other hydroperoxides by glutathione peroxidase (GSH Px). Glutathione forms 
conjugates with a variety of xenobiotics or endogenous reactive compounds, 
aiding in their detoxification and excretion. The intracellular concentration of 
GSH is much higher than that of cysteine, therefore, it may act as a storage 
and transport form of cysteine. Glutathione regulates cellular metabolism, 
catalysis, and transport by reversible addition to protein thiols. Glutathione 
also maintains the structural integrity of cell membrane and the membranes of 
intracellular organelles (1). Glutadiione status may be significant (4,5) in HIV 
infection , because, in HIV+ individuals, GSH levels of T cells are decreased 
(4), cytokine-stimulated HIV transcription is enhanced by depleted 
intracellular GSH (5), and the stimulation of HIV transcription by cytokines is 
inhibited by N-acetylcysteine, a cysteine analog that can increase cellular 
GSH (5,6). 
Although glutathione performs broad and diverse functions in cells, the 
role of GSH in protein modification during oxidative stress may be especially 
important. Oxidative stress describes the situation in which the balance 
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between prooxidants and antioxidants in a cell is disturbed in favor of the 
prooxidants (7). Many chemicals are known to be able to generate oxidative 
stress. During oxidative stress, reactive oxygen species are generated 
enzymatically and non-enzymatically. These reactive species include 
superoxide anion (O2 singlet oxygen, hydrogen peroxide, hydroxyl radical, 
and lipid peroxides. In healthy cells, defense mechanisms can metabolize or 
remove these reactive products, however, in some cases this ability is 
overwhelmed by the rate of generation of reactive intermediates. In this 
situation, irreversible oxidative damage is induced and finally causes cell 
injury or cell death. 
During oxidative stress, glutathione peroxidase (GSH Px) catalyzes the 
removal of reactive intermediates accompanied by the oxidation of GSH to 
glutathione disulfide (GSSG). In the presence of great concentrations of 
GSSG, a specific protein modification occurs, referred to as protein S-
thiolation. Protein S-thiolation is the formation of mixed-disulfides between 
protein reactive sulfhydryls and low molecular weight thiols, such as GSH, 
cysteine, and cysteamine. Glutathione is present in cells in millimolar 
amounts (1), much greater concentrations than cysteine (2) or cysteamine (9). 
On this basis alone glutathionation is likely to be the major type of S-
thiolation. 
Protein S-thiolation has been proposed to play an important role in 
cellular response to oxidative stress. By preventing the loss of membrane 
protein thiols, S-thiolation may protect sensitive membrane s tincture against 
damage (10,11). By preventing irreversible oxidation that results in protein 
degradation, S-thiolation may protect important cellular proteins from 
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oxidative damage (12-14). Moreover, Gilbert proposed that protein S-
thiolation/dethiolation (reduction of mixed-disulfides) may play as a 
regulatory role on enzyme activities and these biological disulfides may act as 
"the third messenger" (15). Rabbit muscle phosphofructokinase (PFK) 
activity varies between 2 and 80% as the GSH/GSSG ratio is varied between 0 
and 25 (15). It has been generally held that the concentration of GSSG in 
vivo is relatively small and that the ratio of GSH/GSSG is relatively large. 
Vina et al. (16) reported that the ratio of GSH to GSSG may vary between 5 
and 20 in vivo. Thus, Gilbert believed that the PFK activity can be regulated 
in vivo by disulfides. 
The best example of the regulatory effect of protein S-thiolation on 
enzyme activity, is its effect on glucose metabolism. Enzymes of glycolysis 
and gluconeogenesis have been studied in vitro and they are activated or 
inhibited by protein S-thiolation (10,15,17). During oxidative sti-ess, by the 
action of GSH Fx, GSSG is generated. To keep a balance of cell thiols and 
prevent the accumulation of GSSG, GSSG is reduced to GSH by GSH 
reductase with the consumption of NADPH. Therefore, the provision of 
sufficient cellular NADPH is required to maintain normal GSH regeneration. 
Once cellular GSSG is increased, it may stimulate protein S-thiolation, 
tiiereby activating enzymes producing glucose-6-phosphate. Then, glucose-6-
phosphate can be used for NADPH production by the action of glucose-6-
phosphate dehydrogenase. Meanwhile, an increase in cellular GSSG would 
activate gluconeogenesis and glycogenolysis and inhibit glycolysis and 
glycogen synthesis. Thus, modulation of thiol/disulfide ratio in vivo could be 
a major metabolic regulator. Glycogen phosphorylase (18), fmctose-1,6-
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bisphosphatase (19), glucose 6-phosphatase (20), and glucose 6-phosphate 
dehydrogenase (21) activities are activated by disulfide formation, whereas 
the activities of glycogen synthetase D (22), phosphofructokinase (15), 
hexokinase (23), pyruvate kinase (24), and glycogen phosphorylase 
phosphatase (25) are inhibited by disulfide formation. 
Because there is a strong correlation between GSSG level and the S-
thiolated protein formation (26-28), S-thiolation by a mixed-disulfide 
exchange reaction is generally accepted as the major mechanism in vivo 
(15,17). This reaction may occur either spontaneously or by enzymatic 
catalysis (17). However, protein S-thiolation can occur under conditions 
where the amount of GSSG is insufficient to generate protein S-thiolation 
(12,29,30). A second mechanism, an oxyradical-initiated process, has been 
proposed by Thomas et al. (14) also to play an important role in this reaction. 
In this mechanism, protein reactive sulfhydryls are capable of forming rather 
stable thiyl radicals in the presence of oxyradicals. These protein thiyl 
radicals then react with reduced GSH to form mixed disulfides. In an in vitro 
enzyme system, creatine kinase, glycogen phosphorylase b, and carbonic 
anhydrase III (CA III) could be S-thiolated under such conditions (12,29). 
Furthermore, protein S-thiolation in macrophages, which contain little GSH, 
also can be initiated by treatment with phorbol diester (30). Under the 
experimental conditions, there was no detectable change in GSSG. 
The importance of each of these two mechanisms to protein S-thiolation 
may depend on several factors, such as cell type, cellular GSH level and 
oxidative reagents. Cells, such as hepatocytes, which have large amounts of 
cellular GSH may use thiol-disulfide exchange for protein S-thiolation but 
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cells, such as macrophages or neutrophils in which the cellular GSH is 
relatively low, may use predominantly an oxyradical-initiated process to 
generate thiolated proteins. Also, reagents, such as menadione, that may 
abruptly increase GSSG formation could produce S-thiolated proteins 
primarily by mixed-disulfide exchange. 
The proteins that are modified by S-thiolation may be returned to their 
native form by a dethiolation reaction. At least three mechanisms have been 
proposed to participate in dethiolation (14). These include two enzymatic and 
one nonenzymatic reaction. Enzymatic dethiolation is dependent on a system 
of dethiolases (31,32), including thioredoxin and glutaredoxin (also called 
thioltransferase). It has been suggested that thioredoxin, when reduced by 
NADPH along with thioredoxin reductase, or glutaredoxin, when reduced by 
GSH, may reduce S-thiolated protein (31,32). The nonenzymatic reaction is 
dethiolation through reaction between GSH and protein-SSG by thiol-
disulfide exchange. For rat hepatic S-thiolated CA III, enzymatic mechanisms 
are more effective in dethiolation (13). Through reversible 
thiolation/dethiolation, mixed-disulfides may therefore possibly function in 
metabolic regulation and to protect protein sulfhydryls under oxidative stress. 
Currently, in studying protein S-thiolation, several methods are widely 
used, including sodium borohydride (NaBH^) reduction, isoelectiic focusing 
analysis, and a radioisotope-based method. By measuring the amount of GSH 
released from a NaBH4 treated sample which had been precipitated with acid 
to remove acid soluble GSH, glutathione-protein mixed disulfides can be 
grossly quantitated (17,26). Isoelectric focusing is another useful technique in 
studying proteins modified by GSH (33). The addition of glutathione to a 
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protein usually changes the protein's net charge at physiological pH by -1 (the 
addition of an NH3+ and a COO" group from glutamate and a COO" from the 
glycine residue of GSH). Additional GSH bound to protein sulfhydryls would 
generate further changes in charge. Thus, S-thiolated proteins would migrate 
and focus at different positions from their native state. S-Thiolation/ 
dethiolation of creatine kinase, glycogen phosphorylase b, and CA in have 
been studied by using this technique (12,13,32). A radioisotope-based method 
provides another option in determining protein S-thiolation (34). In this 
method, cells are pretreated with cycloheximide to block protein synthesis, 
then cells are fed with L-(35S)cysteine and/or L-(35S)methionine. In this 
system, cells can use these radiolabeled amino acids for synthesis of 
(35S)GSH without incorporation of 35S into proteins because protein synthesis 
is blocked. Therefore, proteins which have been S-thiolated with GSH can be 
detected by autoradiography after separate on either SDS-polyacrylamide gels 
or lEF gels. This method has been applied to many cell systems such as rat 
cardiac cells, hepatocytes, macrophages and even 3T3-L1 cells, and S-
thiolation of specific proteins has been demonstrated when those cells are 
under oxidative stress (14,30,35). 
Although these methods are useful in studying protein S-thiolation, the 
methods also have limitations. For instance, in the radioisotope-based 
method, a protein synthesis inhibitor is required for measuring the formation 
of S-thiolated proteins in cells, however, a protein synthesis inhibitor such as 
cycloheximide may be toxic to cells, which interferes with the interpretation 
of results. Rapidity and sensitivity are otiier concerns. On lEF gels, all 
cellular proteins are stained by Coomassie-blue which produces a complex 
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pattern, in which it is difficult to measure altered migration of S-thiolated 
proteins. With regard to the NaBH^ reduction method, it only measures the 
total amount of GSH released and lacks specificity. Thus, a method that 
maintains the advantage of lEF analysis to separate different forms of S-
thiolated proteins but with greater specificity and sensitivity may provide a 
more useful tool in studying protein S-thiolation. 
Western blotting, transferring proteins from SDS-polyacrylamide gels to 
nitrocellulose sheets under electric current was first described by Towbin et 
al. (36) in 1979. Since that time, numerous reports have dealt with the topic 
of protein electrophoretic technique (37,38). This technique has also been 
applied to DNA and RNA blotting (39,40). The proteins immobilized on 
nitrocellulose membranes were then detectable by immunological procedures. 
Nonspecific binding of proteins is minimized by blocking agents such as 
BSA, skim milk, or preimmune serum, then a specific antibody is bound, 
followed by addition of a secondary antibody against the first antibody. 
Generally, the second antibody is either conjugated with fluorescein or 
peroxidase, or prelabeled with radioactivity. Thus, the specific protein can be 
detected under UV light, by the color development of the peroxidase reaction 
product, or by autoradiography. As low as pg amounts of protein could be 
detected by the antibody-peroxidase conjugate. It is, therefore, useful to 
determine the applicability of combining lEF analysis and Western blotting to 
detect protein S-thiolation. By this combination, the sensitivity and 
specificity of immunostaining and separation of nonthiolated and S-thiolated 
forms of a protein can be achieved. Because of the different properties of the 
denatured SDS-polyacrylamide gel system and the nondenatured lEF gel 
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system, several steps of this traditional blotting method need to be adjusted as 
discussed in Section I. 
Carbonic anhydrase HI (CA m), one of the CA isoenzymes, has been 
identified in many tissues (41-43); however, the liver and red skeletal muscle 
(type I fibers) are the only tissues that have large amounts of CA in (44-46). 
This protein was first identified and purified in 1977 from chicken and sheep 
skeletal muscle (44). It had been accepted that this enzyme was present 
exclusively in skeletal muscle when, in 1981, large amounts of CA in were 
found in mature male rat liver (45). The level of CA III in male rat liver was 
estimated at approximately 5-8% of the total soluble cytosolic protein (47,48). 
This enzyme was also found in female rat liver but at only 3% to 7% of the 
amount found in males (45,47) depending on the strain of rats examined. The 
sexual dimorphism of CA III was proposed to be regulated, at least in part, by 
the difference in growth hormone releasing pattern between male and female 
rats (49,50). 
Since carbonic anhydrase was first discovered by F. W. Roughton in 
1935 (51) in muscle tissues, over the past 57 years, many CA isoforms have 
been identified from different sources (52). They aie designated as CA I, CA 
n, up to CA VII. Among these CA isoforms, only CA I, CA II and CA III 
have been well characterized. The carbonic anhydrases are zinc 
metalloenzymes that catalyze the simple hydration/dehydration of CO2 and 
H2O (CO2 + H2O <=> HCO3" + H"'") to facilitate the blood transport and 
excretion of CO2. CA II, which is found in most tissues, has the greatest 
activity with an extremely high turnover number (-IxlO^ mol/sec) (42,44). 
CA I exists predominantly in erythrocytes and has about 16% of the activity 
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of CA II (42,44). However, CA III, the most abundant of the CA isoforms in 
red skeletal muscle and rat liver has only 1 -2% the activity of CA II (42,44). 
Why do rat muscle and liver synthesize such great amount of CA III, a 
carbonic anhydrase with little hydration/dehydration activity? An alternative 
explanation is CA HI plays a role in hepatic acid-base homeostasis (52). At 
present, there are no good explanations of the physiological and biochemical 
roles of CA in. 
Recently, CA in (reported as a 30 kDa protein) was observed to be the 
major S-thiolatable protein in male rat liver homogenates treated with either 
GSSG or diamide (53). This 30 kDa protein, thereafter, was purified and 
identified as CA IE (13). Because CA III is present in such large amounts (5-
8% of total cytosolic proteins) in male rat liver and CA III is S-thiolated and 
then can be dethiolated (by dethiolases) (13,32), it is possible that CA HI may 
function as part of an oxidative stress defense system. This defense system 
would use GSH and GSSG to trap reactive reduced oxygen species such as 
H2O2, superoxide anion, and hydroxyl radical produced during oxidative 
stress. CA IE reactive sulfhydryls then react with GSSG or with oxyradicals 
directly to form S-thiolated CA III. Thereafter, S-thiolated CA III could be 
dethiolated to form reduced CA III by the actions of dethiolases. Dethiolases 
will also regenerate reduced GSH, a major intracellular antioxidant, creating a 
cycle which might prevent extensive damage to lipids, other proteins, and 
DNA by oxidative stress. CA III is, thus, chosen as a model molecule to 
further study protein S-thiolation in vitro and in vivo. 
The function and metabolism of GSH has been discovered by the study 
of mutants that are deficient in particular enzymes, and/or by using several 
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protocols that can modulate intracellular GSH level (3). One of the tools of 
major importance is the development of the selective GSH synthesis inhibitor, 
buthionine sulfoximine (BSO), by Griffith and Meister in 1979 (54). Other 
methods that are widely used in modulating GSH by either decreasing or 
increasing it, include, for example, the use of diethyl maleate (DEM) to 
reduce GSH through conjugation (55,56). Treatment of cells or animals with 
various cysteine derivatives, such as L-2-oxothiozolidine-4-carboxylate or N-
acetyl-L-cysteine, has also been reported to effectively increase intracellular 
GSH (5,6,57-60). These two cysteine derivatives can be enzymatically 
converted to L-cysteine which then acts as a substrate for GSH synthesis. 
Monoesters of GSH, especially the monomethyl or monoethyl esters (in which 
the glycine carboxyl group is esterified), are also effective in increasing 
cellular GSH in different tissues of mice (61). Such modulation of GSH 
metabolism has been used for studying the relationship between GSH levels 
and cellular protective mechanisms against oxidative damage, radiation, and 
toxic compounds as well as in studies directed toward the therapeutic effects 
of modification of GSH status in the selective destruction of tumor cells 
during chemotherapy or radiotherapy (62-64). 
BSO, a selective inhibitor of y-glutamylcysteine synthetase which 
catalyzes the committed step in GSH synthesis, has been widely used for the 
depletion of cellular GSH. It is relatively nontoxic to animals. Injection of a 
dose of 32 mmole/kg body weight did not produce any toxic effects or 
detectable behavior change in mice over a period of observation of 7 days 
(54). However, a dosage of 2-4 mmole BSO/kg of body weight is effective in 
inhibiting GSH synthesis. The inhibition of GSH fonnation was known to be 
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due to the similarity of BSO to the y-glutamylphosphate cysteine adduct, an 
intermediate during GSH synthesis (65,66). Thus, once the enzyme-BSO 
complex is formed, the active site of the enzyme is irreversibly blocked. In 
addition to BSO, the highly homologous, penta-, hexa, and hepathionine 
sulfoximes are also effective inhibitors of y-glutamylcysteine synthetase but 
are much more toxic to animals (67). As BSO was administrated 
intraperitoneally or subcutaneously to mice or rats at a single dose of 4 
mmole/kg body weight, the GSH levels in the liver and kidney decreased 
rapidly during the first 2 h to about 20% of the untreated control and this low 
level was maintained for next 7 to 10 h and then increased gradually toward 
the control level (68). In studies on human lymphoid cell lines, cellular GSH 
was depleted rapidly to about 5% of the control level during a 24 h incubation 
with 1 mM BSO. GSH continued to decrease for the next 26 h (62). 
Depletion of GSH to about 5% of the control level in those human lymphoid 
cells resulted in a marked increase in sensitivity to radiation. In other types of 
cells, especially tumor cells, similar results has also been obtained in 
sensitizing them to radiation or to drugs by the use of BSO to deplete cellular 
GSH. (61,63,64,69). 
Menadione and t-butyl hydroperoxide are two reagents widely used to 
study oxidative stress in liver cells. The metabolism of menadione has been 
studied in subcellular fractions (70) and in isolated cell systems (71) and it has 
been shown to undergo either one-electron or two-electron reduction. With 
the action of various flavoprotein reductases, the one-electron reduction of 
menadione produces a semiquinone free radical (71). In the presence of O2, 
this semiquinone can be reoxidized to the parent molecule accompanied by 
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the production of superoxide anion and other oxyradicals (71,72). This 
generation of oxyradicals by a redox cycling mechanism thus initiates a series 
of cytotoxic events (71,73,74). Other reactions that do not generate 
oxyradicals, such as the conjugation of menadione with GSH and the 
alkylation of menadione with cellular macromolecules, are also involved in 
menadione's cytotoxicity (75,76). With the formation of superoxide anion as 
a consequence of redox cycling, H2O2 is generated by the dismutation of 
superoxide dismutase. The oxidation of GSH to GSSG which accompanies 
the detoxification of H2O2 by GSH Px increases intracellular GSSG. As a 
result, protein S-thiolation can be initiated by menadione, either by thiol-
disulfide exchange or by oxyradicals directly. GSH-protein mixed disulfide 
formation was concentration dependent over the range of 0.025 to 0.4 mM 
menadione(27). CA in (reported as 30 kDa protein) was reported to be the 
major S-thiolated protein in male rat liver by the treatment of menadione (53). 
t-Butyl hydroperoxide is known to be metabolized by GSH Px to form 
GSSG. Due to the steric hindrance of the methyl groups around the 
hydroperoxide group, t-butyl hydroperoxide cannot be detoxified by catalase. 
Moreover, the hydrophilicity of t-butyl hydroperoxide prevents it from being a 
substrate for GSH S-transferase and allows it to be used easily in aqueous 
media. Thus t-butyl hydroperoxide provides a useful model hydroperoxide in 
studying the functions of GSH Px in cells during oxidative stress. Most of the 
GSSG formed in this reaction is then reduced by GSH reductase. GSH is 
regenerated with the consumption of NADPH. However, the large amounts of 
intracellular GSSG produced within a short time after t-butyl hydroperoxide 
administration initiates protein S-thiolation by mixed/disulfide exchange, t-
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Butyl hydroperoxide can also generate oxyradicals in treated cells (77) and 
therefore the possibility cannot be excluded that S-thiolation may partly result 
from an oxyradical-initiated mechanism during t-butyl hydroperoxide 
treatment. 
Perfusion of rat liver with 0.1 mM t-butyl hydroperoxide caused a 34% 
increase in glucose-6-phosphate dehydrogenase activity, which was thought to 
be related to an increase in protein S-thiolation (78). During t-butyl 
hydroperoxide infusion, a marked increase of GSSG and decrease of GSH 
was also found. In rat cardiac cells and hepatocytes, protein S-thiolation of 
CA III (reported as 30 kDa) and glycogen phosphorylase b (reported as 97 
kDa) (14,35,53) was also initiated with t-butyl hydroperoxide treatment. 
Paraquat is another chemical that can cause oxidative damage. Paraquat 
(1,1 '-dimethyl-4,4'-bipyridyl) is a broad spectrum herbicide and is widely used 
in many countries. However, many accidental as well as intentional 
poisonings in humans (79,80) and toxicity in mammals (81,82) have been 
reported. Although the mechanisms of paraquat intoxication have not been 
fully defined, its redox cycling properties are considered to be the major 
mechanism in interfering with normal cell functions (83-85). By this redox 
cycling, the generation of reactive oxygen species, such as singlet oxygen, 
superoxide anion, hydrogen peroxide, and hydroxyl radicals, and/or as a 
consequence of depleting cellular reducing equivalents such as NADPH, 
paraquat may be responsible for perturbing important aspects of cell 
metabolism. 
The existence of such a redox mechanism for paraquat toxicity in vivo is 
supported by the findings that paraquat toxicity in rats is increased by 
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exposure to O2 (86,87) and can be decreased by treatment with superoxide 
dismutase (87). Moreover, paraquat toxicity is increased in rats fed a diet 
deficient in selenium or vitamin E (88-90) or administered diethyl maleate 
(55,88). Selenium is required for normal GSH Px activity, and diethyl 
maleate depletes intracellular GSH level. Vitamin E, GSH, and GSH Px are 
all important antioxidants that protect cells from oxidative damage. The toxic 
effects caused by paraquat include induction of lipid peroxidation (88,89), 
reduction of fatty acid synthesis (91), inhibition of DMA synthesis (92), and 
cytoskeletal perturbation (93). One consequence of such oxidative stress 
caused by paraquat may include the formation of S-thiolated proteins. As 
reported by Brigelius et al. (26), a 50% increase in intracellular S-thiolated 
proteins compared with untreated controls was observed in rat liver perfused 
with paraquat. Lung, the main target tissue for paraquat toxicity, experienced 
increased protein S-thiolation after rats were administered paraquat, 20 mg/kg, 
subcutaneously, for 2 h (91), although GSH and GSSG levels remained 
unchanged. The evidence suggests that protein S-thiolation can be initiated 
by paraquat. 
Glutathione peroxidase (GSH Px), a selenoprotein, is one of the enzymes 
that plays an important role in protecting cells from oxidative damage. Mills 
described GSH Px in 1957 (93) as an enzyme that prevented hemoglobin 
oxidation by hydrogen peroxide. He also reported that GSH was involved in 
this reaction. Now, it is clear that GSH Px not only catalyzes the 
detoxification of hydrogen peroxide but of many other organic 
hydroperoxides (94,95) with reduced GSH and thus functions in the protection 
of cells against oxidative damage. In this reaction, hydroperoxides are 
15 
reduced to alcohols accompanied by the oxidation of reduced GSH to GSSG, 
Glutathione disulfide, thereafter, is converted back to GSH by GSH reductase 
with the consumption of NADPH. In addition to GSH Px, glutathione S-
transferase also has GSH peroxidase activity (96). It was noted that some 
peroxidase activity was unrelated to selenium deficiency by Lawrence and 
Burk (97), who identified a Se-independent GSH Px activity from a Sephadex 
G-150 column and a Se-dependent GSH Px fraction by using two substrates, 
cumene hydroperoxide and H2O2. Generally, these two peroxidases can be 
distinguished by the inability of GSH S-transferase to catalyze the reduction 
of hydrophilic hydrogen peroxide or t-butyl hydrogen peroxide (98). 
Based on the requirement of Se for maintaining GSH Px activity, Se has 
been widely used to study the role of GSH Px and the oxidation of GSH in 
cells during oxidative stress or during drug metabolism. Many reports have 
indicated that once GSH Px is dramatically decreased by feeding animals with 
a Se-deficient diet, animals or cells isolated from those animals are sensitized 
to many drugs and chemicals such as paraquat (55,89,99), acetaminophen 
(100), diquat (89), and carbon tetrachloride (100,101). It is thought that in the 
Se-deficient state, those oxyradicals generated from paraquat cannot be 
efficiently removed by GSH Px which thus increases paraquat toxicity. 
However, the effect of Se on other proteins or enzymes cannot be excluded 
from some roles in the enhancement of chemical toxicity during Se 
deficiency. It is now clear that most Se in the rat is not bound to GSH Px 
(102). For instance, the highest concentration of Se occurs in testis, while the 
highest GSH Px activity in liver is 50 fold greater than in testis. To date, 
several selenoproteins have been detected in rat tissue homogenates after in 
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vivo labeling with (75Se)selenite (103) and three selenoproteins have been 
purified from animals, including GSH Px, selenoprotein P (104),and 
phospholipid hydroperoxide glutathione peroxidase (105). With the exception 
of GSH Px, the role of other selenoproteins has not been clearly defined. 
While the effect of Se-deficiency on GSH Px activity is well-known, the 
effect of Se deficiency on other aspects of GSH metabolism has also been 
reported. The activities of GSH S-transferase (100) and y-glutamylcysteine 
synthetase (106) were significantly increased in Se-deficient rats compared 
with controls. However, the hepatic GSH concentration was not affected by 
Se. Meanwhile, the plasma GSH level was twice as much in Se-deficient rats 
as in controls (100). It was suggested that the increase of GSH synthesis is 
balanced by the increased release of GSH into the blood (106). In contrast, a 
3-fold increase of GSH concentration was reported in chick liver from a Se-
deficient group compared with controls (107). 
Selenium, as an essential element for the GSH Px, causes a severe loss of 
GSH Px activity, usually in animals fed a Se-deficient diet, less than 2% of 
controls (108). Thus, the use of hepatocytes isolated from rats fed a Se-
deficient diet to decrease Se-dependent GSH Px activity provides a possible 
model to study the mechanism of protein S-thiolation. Selenium deficiency 
would be expected to limit the formation of GSSG, a product of GSH Px 
activity. Therefore, if protein S-thiolation depends upon GSSG-protein mixed 
disulfide exchange, protein S-thiolation may be suppressed in Se-deficiency. 
The objectives of this thesis are addressed in three parts. First, the 
development of a method that can specifically and sensitively detect protein 
S-thiolation is described. Secondly, the possible mechanisms that initiate 
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protein S-thiolation are distinguishing in Se-deficient and Se-adequate 
hepatocytes. Third, this new method is applied to an in vivo experiment to 
examine the occurrence of protein S-thiolation in Se-deficient and Se-
adequate animals during oxidative stress. 
Explanation of Dissertation Format 
This dissertation contains three papers, each of which has its own 
abstract, introduction, materials and methods, results, discussion, and 
references. These papers will be submitted to scientific journals for 
publication, with modifications to meet the journal's format requirements. 
Following these papers are the summary and conclusions of this dissertation. 
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PAPER 1: WESTERN BLOTTING OF ISOELECTRIC FOCUSIING GELS: 
A METHOD TO DETECT S-THIOLATION OF SPECIFIC 
PROTEINS 
19 
WESTERN BLOTTING OF ISOELECTRIC FOCUSIING GELS: A 
METHOD TO DETECT S-THIOLATION OF SPECIFIC PROTEINS 
Chong-Kuei Lii. James A. Thomas*, and Suzanne Hendrich^ 
Department of Food Science and Human Nutrition 
^Department of Biochemistry and Biophysics 
Iowa State University, Ames, lA 50011 
iTo whom correspondence and reprints requests should be addressed 
20 
ABSTRACT 
Isoelectric focusing (lEF) combined with Western blotting detected the 
modification of carbonic anhydrase III (CA HI) by S-thiolation (glutathione-
protein mixed disulfide formation) when primary cultures of rat hepatocytes 
were subjected to oxidative stress. Carbonic anhydrase HI constitutes 5-8% of 
the soluble protein in male rat liver, and is the major hepatic protein modified 
by S-thiolation in males. Carbonic anhydrase III antiserum was produced by 
immunization of a rabbit with purified CA HI. As little as 10 ng of CA III 
could be clearly identified on Western blots of lEF gels. With this method, 
three S-thiolated forms of CA III could be detected in hepatocytes treated with 
0.2 mM menadione, however, only two S-thiolated forms of CA III were 
observed in hepatocytes treated with 0.5 mM t-butyl hydroperoxide. S-
thiolation of CA III by t-butyl hydroperoxide reached a maximum at 3 min 
and decreased to control levels by 15 min, whereas menadione gradually 
increased CA III S-thiolation. These results support the concepts that CA III 
has two reactive sulfhydryl groups and that S-thiolation can occur in different 
ways. A similar CA III S-thiolation pattern was observed in female 
hepatocytes under oxidative stress, although CA III levels in females were 15-
fold less than in males. CA III S-thiolation was also detected in rat muscle 
and heart and the blotting pattern of S-thiolated proteins was similar to the 
pattern in liver. This method may permit molecular characterization of the 
regulation of numerous specific proteins which are modified by oxidative 
stress and consequent S-thiolation in vitro and in vivo. 
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INTRODUCTION 
Protein S-thiolation, a mixed-disulfide of protein reactive sulfhydryls 
(cysteine residues) and low molecular weight thiols such as glutathione 
(GSH), has been proposed to play an important role in cellular response to 
oxidative stress. S-thiolation may protect sensitive membrane structures 
against damage (1,2), regulate enzyme activities to meet the cell's metabolic 
requirements (1,3), or protect important cellular proteins from irreversible 
oxidation (4,5). The regulatory role of S-thiolation/dethiolation (reduction of 
S-thiolated cysteine residues) in enzyme activities, as proposed by Brigelius 
(1) and Gilbert et al. (6), may be similar to the well-known regulation of 
enzymes by phosphorylation-dephosphorylation. The best example is the 
effect of S-thiolation on glucose metabolism. Under oxidative stress, the 
enzymes which favor the shunting of glucose metabolism to the pentose 
phosphate cycle are activated, such as glucose-6-phosphate dehydrogenase, 
fructose-1,6-bis-phosphatase, and glycogen phosphorylase a. A 34% increase 
in glucose-6-phosphate dehydrogenase activity was observed when rat liver 
was perfused with 0.1 mM t-butyl hydroperoxide (7). Activation of this 
pathway increases NADPH production which is needed for glutathione 
reductase activity, a crucial enzyme in protecting cells from oxidative stress. 
Conversely, the enzymes favored for glycolysis such as phosphofructokinase 
and pyruvate kinase are inactivated (1). 
Through the thiolation and dethiolation process, many proteins with 
reactive sulfhydryl groups may also be protected to prevent the formation of 
other oxidized forms that result in protein degradation. Under oxidative 
stress, protein S-thiolation occurs. During the cellular recovery period or 
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continuously during oxidative stress, S-thiolated proteins can be reduced to 
their native form by either enzymatic or nonenzymatic dethiolation. Recently, 
the thiolation/dethiolation of carbonic anhydrase in (CA III), phosphorylase b 
and creatine kinase (5,8-11) have been described. 
Carbonic anhydrase in, a major cytosolic protein, was first identified 
and purified in 1977 from chicken and sheep red skeletal muscle (12). It had 
been accepted that this enzyme was present exclusively in skeletal muscle, 
when, in 1981, large amounts of CA III were found in mature male rat liver 
(13) at levels approximately 5-8% of total soluble cytosolic protein (13,14). 
This enzyme is also present in female rat liver, at only 3% to 7% of the level 
found in males (14,15) depending upon the strain of rats examined. Several 
different carbonic anhydrase isozymes have been identified from different 
sources(16). But, only the CA I, CA H, and CA III forms have been well 
characterized. CA I exists predominantly in erythrocytes and has about 16% 
of the activity of CA 11(12). CA II, with the greatest enzymatic activity, is 
found in most tissues(16). However, CA III, the most abundant protein in red 
skeletal muscle and rat liver has only 2% of the activity of CA II (12). Why 
do rat muscle and liver tissues synthesize such great amounts of CA III, a 
carbonic anhydrase isoenzyme with littie hydration activity? Of what benefit 
can this apparently uneconomical protein synthesis be? At present, there are 
no clear explanations of the physiological and biochemical roles of CA III. 
Isoelectric focusing is a very useful technique in studying proteins 
modified by glutathione S-thiolation (5,8-11). The addition of glutathione to a 
protein usually changes the protein's net charge at physiological pH by -1 (the 
addition of an NH+3 and a COO" group from glutamate and a COO" from the 
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glycine residue of glutathione). Additional glutathione/protein mixed 
disulfides would generate further changes in charge. Thus, each band of 
purified CA in on an lEF gel represents a different modified form. But, 
protein staining does not provide sufficient sensitivity or specificity to make 
the method of general use. Alternatively, an radioisotope-based method is 
currently used to study protein S-thiolation (17) but has some limitations. 
Therefore, a method with more sensitivity and also with the advantages of lEF 
analysis is necessary to quantify protein modification during oxidative stress 
in vitro and in vivo. 
This paper describes a method combining the blotting of lEF gels and 
immunostaining to study protein S-thiolation in order to understand the 
regulatory significance of this type of protein modification during conditions 
of oxidative stress in cultured rat hepatocytes and in other rat tissues, i.e., 
heart and skeletal muscle. The method was also used to explore differences in 
S-thiolation of CA III in male and female rat hepatocytes. 
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MATERIALS AND METHODS 
Materials 
lodoacetamide, dithiothreitol, bovine serum albumin, HEPES, sodium 
selenite, tert-butyl hydroperoxide, menadione, phenylmethylsulfonyl fluoride 
(PMSF), benzamidine, leupeptin, human CAI and CA 11, and bovine CA n 
were obtained from Sigma Chemical Co. (St. Louis, MO). Insulin, transferrin, 
penicillin-streptomycin, and L-15 medium were purchased from Gibco 
Laboratories (Grand Island, NY). Collagenase (type I) was obtained from 
Worthington Biochem Co. (Freefold, NJ). GelBond was from FMC Corp. 
(Rockland, CA). Ampholytes and Percoll were from Phannacia LKB 
(Piscataway, NJ). Peroxidase anti-rabbit IgG kit was obtained from Vector 
Laboratories, (Burlingame, CA). All other reagents used were reagent grade 
or better. 
Antibody Production 
Purified rat liver CA III was prepared as previously described by Chai 
et al. (5). One hundred micrograms of purified CA III was injected 
subcutaneously (SC) in a 1:1 mix with Freund's complete adjuvant (0.5 ml) 
into one 6 month-old male New Zealand rabbit, and a 100 jig booster injection 
in a 1:1 mix with incomplete Freund's adjuvant (0.5 ml) was administered SC 
2 weeks after the first injection. Antiserum was prepaied by biweekly 
bleeding from the ear vein beginning one month after the initial injection of 
antigen. Antibody titer was determined by dot immunoassay (18) and a 1:500 
titer was shown to be optimal for CA III detection. Human erythrocyte CA I 
(hCA I), CA II (hCA II), and bovine erythrocyte CA II (bCA II) were used to 
test rat liver CA III antibody specificity. 
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Hepatocyte Isolation 
Male (200-250 g) and female (150-200 g) Sprague-Dawley rats of the 
same age (Sasco Co., Omaha, NE) were used to prepare hepatocytes. Water 
and a crude cereal-based diet were offered ad libitum. Rat hepatocytes were 
isolated according to the method described by Berry and Friend (19) and 
Bonney et al. (20) with several modifications. Male and female rats were 
anesthetized with sodium pentobarbital (100 mg/kg body weight). Liver was 
first perfused via the portal vein with 150 ml of perfusion medium, pH 7.6, 
containing 25 mM Na2HP04, 3.1 mM KCl, 119 mM NaCl, 5.5 mM glucose, 
0.1% BSA, and 0.0005% phenol red (21). After 7 min of perfusion (25 
ml/min), the medium was replaced by 200 ml of the same buffer 
supplemented with 70 mg Type I collagenase, 4 mM CaCl2, and 5 mg trypsin 
inhibitor. After perfusion at the rate of 18 ml/min for 8 min, cells were 
harvested. This collagenase-treated liver was sieved through a nylon mesh 
into a flask and washed with L-15 washing medium, pH 7.6, supplemented 
with 18 mM HEPES, 0.2% BSA, 0.05% glucose, and 5 jig/ml insulin. The 
cell suspension was centrifuged at 200 rpm (International Equipment Co., lEC 
EXD centrifuge, Needham Heights, MA) for 3 min and washed again. After 
washing, cells were resuspended in a Percoll solution (10% lOX Hank's buffer 
plus 90% Percoll) and centrifuged at 500 rpm to remove dead cells and 
nonparenchymal cells (22). The pellets were then resuspended, and washed 
twice to remove the Percoll residue. Cell viability was determined by trypan 
blue exclusion and was greater than 90%. 
Cell Cultures 
After Percoll centrifugation and washing, the isolated hepatocytes were 
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resuspended in L-15 cell culture medium, pH 7.6, supplemented with 18 mM 
HEPES, 0.2 % BSA, 5 |Xg/ml each of insulin, and transferrin, 5 ng/ml sodium 
selenite, 5 mg/ml galactose, 1 |iM dexamethasone, 100 lU/ml penicillin, and 
100 ng/ml streptomycin, at a final concentration of 0.5x10^ cells/ml. Five 
milliliters of this cellular suspension (2.5x106 cells) were plated on each 
collagen-precoated 60 mm plastic tissue culture dish (Fisher Sci. Co., 
Chicago, IL), and placed into a 37°C humidified incubator in an air 
atmosphere. The first change of culture medium was performed 4 h after 
plating to remove dead and unattached cells. Then the medium was changed 
once each day. 
After 48 h, the cells were switched to L-15 medium, pH 7.6, contained 
18 mM HEPES. After 15 min of equilibration, cells were tieated either with 
0.5 mM t-butyl hydroperoxide or 0.2 mM menadione (personal 
communication with Y.-C. Chai) at 37°C for times as indicated in Figures 3 
and 6. The reaction was stopped by removing medium and rinsing with cold 
20 mM phosphate buffer saline, pH 7.4. Cellular soluble fractions were 
prepared by scraping cells in 100 |il sample buffer, pH 7.4, containing 20 mM 
HEPES, 5 mM EDTA, 5 mM EGTA, 0.1 mM PMSF, 1 mM benzamidine, 4 
|ig/ml leupeptin and 50 mM iodoacetamide (lAM). Cell homogenates were 
centrifuged at 10,000g for 30 min at 4°C and these particulate-free extracts 
were used for lEF analysis. Samples for complete reduction with 
dithiothreitol (DTT) contained no JAM. Protein concentiations were 
determined by the method of Lowry et al. (23). Glutathione and GSSG were 
measured by a HPLC method (24). 
Tissue Preparations 
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Rat were anesthetized with sodium pentobarbital (100 mg/kg body 
weight) before opening the peritoneal cavity. Liver, heart, and hind-leg 
muscle were removed inmiediately and 0.5 g of each sample were 
homogenized with a Teflon-glass homogenizer in 5 ml of cold HEPES buffer 
(ph 7.4), containing 5 mM EDTA, 5 mM EGTA, 0,1 mM PMSF, 1 mM 
benzamidine, 4 |ig/ml leupeptin and 50 mM iodoacetamide (lAM). Tissue 
homogenates were centrifuged at 10,000 g for 15 min at 4°C and supematants 
were used for lEF analysis. 
Isoelectric Focusing Gel Analysis 
S-thiolated CA III was analyzed by thin-gel isoelecti'ic focusing as 
previously described (25). Gels of 4% acrylamide contained 2% LKB 
Ampholytes (1 part of pH 4-6 Ampholyte : 5 parts of pH 5-8 Ampholytes 
were used). Gels were poured on NetFix (Serva Biochem. Inc., Westbury, 
NY), a mesh backing that stabilizes the gel during transfer from the GelBond 
support to the Western blotting transfer chamber. Gels were prefocused for 10 
min before sample loading. Purified CA III and hepatocyte soluble fractions 
were applied to a sample application strip (Serva) on the anodic side of the 
gel, and samples were focused for 50 min. The limiting voltage was 1,500 V 
and the limiting current and power were dependent on the gel size, 
approximately 2.75 mA/cm and 1.125 W/cm gel width. After isoelectric 
focusing, gels were either stained as described (25) or blotted to a 
nitrocellulose membrane. 
Western Blotting 
Western blotting was performed as described (26) with some 
modifications. After electrofocusing, the thin-gel with mesh was separated 
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from the GeîBond and put into cold 0.7% acetic acid solution immediately. 
The time from the end of the isoelectric focusing to the beginning of blotting 
was minimized to avoid protein diffusion in the gel. 0.7% cold acetic acid 
solution was also used as blotting buffer and blotting was performed at 
constant voltage, 100 V (Power Supply, Model 200/2.0, Bio-Rad, CA), for 2 
h. In contrast to the blotting system for SDS-PAGE gels, the proteins have a 
net positive charge in this acidic system and the blotting membrane was 
placed on the cathodic side of the gel for transfer. For good blotting 
efficiency, acetic acid solution was kept cold throughout the blotting period. 
Immunodetection of CA III 
The nitrocellulose membranes were stained by the method of Obata and 
Cheng (18) with some modifications. Nonspecific binding to membranes was 
blocked with 1% BSA in 15mM Tris/150 mM NaCl buffer, pH 7.4, then 
membranes were treated with rabbit anti-CA III antiserum. The final titer of 
anti-CA in antiserum was 1:500, An avidin/peroxidase and biotinylated anti-
rabbit IgG kit were used to detect immunoreactive protein bands. Each 
incubation with blocking buffer, primary antibody, secondaiy antibody, and 
avidin-peroxidase complex was 1 h at 37^C. Between each step, membranes 
were washed 4 times with a buffer, pH 7.4, containing 15 mM Tris, 150 mM 
NaCl, and 0.3% Tween-20. Hydrogen peroxide (0.012%) and 3,3'-
diaminobenzidine (0.01%) were used as peroxidase substrates for color 
development by treating membranes at room temperature for 15 min. Finally, 
membranes were air-dried. 
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RESULTS 
To assess the sensitivity and specificity of a rabbit CA HI polyclonal 
antibody in detecting rat liver CA III, two different gel systems, isoelectric 
focusing thin-gel and SDS-PAGE polyacrylmide gel, were compared (Fig. 1). 
Panel A shows the focusing positions of different CA isoforms, ie,, rat liver 
CA in, hCA I or II, and bCA II, on a Coomassie blue-stained lEF gel. Panel 
B shows the immunoreactivity of each CA isoform on nitrocellulose 
membrane after blotting the lEF gels. Results indicated that the anti-CA HI 
serum detected 10-20 ng of rat CA III but detected only 400 ng of the 
isoforms (Fig. IB). Due to the characteristics of the gel system, proteins are 
in their native state on lEF gels, whereas, they are denatured on SDS-
polyacrylamide gels. To determine whether denaturation affects antibody 
specificity, the immunoreactivity of rat CA III and other isoforms on Western 
blots of SDS-polyacrylamide gels are shown in Panel C. CA III is 
approximately 10 times more reactive than the other isofoiTns in this 
denaturing system. 
The S-thiolation pattern of CA III was demonstrated on a Coomassie 
blue-stained lEF gel (Fig. 2). Both purified CA III (lanes 1 and 2) and liver 
homogenates (lanes 3 to 5) were tested. It is apparent that this pattern of CA 
III S-thiolation is consistent in these two different preparations. In the 
presence of 20 mM GSSG, reduced CA in was modified to paitially and fully 
S-thiolated forms and thus focused at positions corresponding with the 
changes in pi due to CA III glutathionation. In liver homogenate treated with 
DTT (lane 5), S-thiolated CA III returned to its reduced form and focused at 
the same position as in lane 3. In the GSSG-treated purified CA III (lane 2), 
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there was a second partially S-thiolated band observed (a light band just above 
the dark first partially S-thiolated band). Similar findings were also observed 
in later experiments where the lEFAVestem blotting method was used to 
detect the S-thiolation of CA in. However, this second partially modified 
protein could not be detected in liver homogenates (lane 4), due to the 
stronger background of the Commassie blue-stained gels. These results 
confirmed that CA III has two reactive sulfhydryl groups with one sulfhydryl 
more reactive than the other. 
Menadione and t-butyl hydroperoxide are two chemicals widely used to 
study oxidative stress in liver cells. As detected by immunostaining, these 
agents caused S-thiolation of CA III in male hepatocytes (Fig. 3). In the 
presence of 20 mM GSSG (Fig. 3 A, lane 1), most of the reduced CA III 
(upper band) was modified to partially- and fully-thiolated forms. This 
observation was consistent with the findings that CA III in rat liver 
homogenates treated with 20 mM GSSG is focused in positions different from 
reduced CA III (Fig. 2). Furthermore, the second partially S-thiolated CA III 
band (a light band at a position between the fully reduced and the dominant 
partially S-thiolated CA III) was also identified by lEFAVestern Blotting. In 
the presence of DTT, this modification was reversible (Fig. 3A, lane 2). The 
reduction of CA III by DTT was not complete because a small amount of 
partially- or fully-thiolated CA III could be detected even in the presence of 
30 mM DTT (Fig 2A). 
S-thiolation of CA III by t-butyl hydroperoxide reached a maximum at 
3 min (Fig. 3B, lane 2) and decreased to its original status at 15 min (lane 4). 
Untreated cells (time 0) also contained some appaientiy modified CA III (lane 
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1). This suggests that S-thiolation occurs in untreated cultured hepatocytes. 
S-thiolation was concomitant with the change in hepatocyte GSH/GSSG ratio 
over time (Table 1). The GSH/GSSG ratio was about 30 in untreated cells but 
decreased to about 1 after 3 min of t-butyl hydroperoxide treatment. This 
ratio was increased up to about 10 after 15 min of t-butyl hydroperoxide 
treatment. There was no change in hepatocyte total GSH among these 
different time points. The time course of CA in S-thiolation by menadione in 
male hepatocytes (Fig. 3C) contrasted with the effects of t-butyl 
hydroperoxide. After menadione treatment, a gradual modification of CA III 
occurred over time and two partially S-thiolated forms were detected. A 
greater change in hepatocyte GSH/GSSG ratio was also observed, with this 
ratio decreasing 100 fold in cells after 7 min of menadione treatment 
compared with the ratio at time 0 (Table 1). 
In observing CA in S-thiolation on lEF gels, it was noted that a portion 
of the partially and fully S-thiolated proteins could not be reduced by DTT 
(Fig. 3A). Therefore, detection of this non-reducible form of CA III was 
attempted in both untreated and menadione-treated hepatocytes. Most of the 
modified CA III in both untreated (lane 1 vs 2) and menadione-treated 
hepatocytes (lane 3 vs 4) was reduced in the presence of DTT (Fig. 4). But, a 
small part of the apparently modified CA III was not reduced by DTT. The 
total amount of nonreducible CA III was similar in menadione-treated and 
untreated hepatocytes. The presence of this non-reducible foiin of CA III in 
untreated cells suggests that some irreversible modification of CA III might 
occur endogenously. 
To clearly demonstrate that this apparently nonreducible protein is 
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also CA ni, its molecular weight and anti-CA III antiserum binding affinity 
were tested (Fig. 5). The protein which was nonreducible after DTT treatment 
and the total apparently partially S-thiolated CA III produced by GSSG were 
cut from the lEF gel and applied to a SDS-polyacrylamide gel. After 
electrophoresis, half of the gel was used for Western blotting (Fig 5A), and the 
other half of the gel was directly silver stained (Fig. 5B). By this analysis, the 
nonreducible and reducible protein have the same molecular weight (30 kDa) 
and similar antibody binding reactivity (by comparing the relative band 
intensity of lanes 1 and 2 with that of lanes 3 and 4). 
To examine this irreversibly modified CA III, hepatocytes were 
prepared at several time points during culture. The amounts of nonreducible 
CA in increased gradually with time from 0 h to 48 h after perfusion. Even 
freshly isolated hepatocytes contained nonreducible CA III. These results 
show that usual culture conditions can produce modifications other than S-
thiolation. 
Given the greatly different amount of CA III in male and female rat 
liver, it was interesting to know if CA III responded to oxidative stress in the 
same manner in both sexes (personal communication with Y.-C. Chai). A 
pattern of CA ni S-thiolation similar to male hepatocytes (Fig. 3B) was 
observed in female cells treated widi t-butyl hydroperoxide (Fig. 6), when the 
Western blot method was used. A higher concentration of soluble proteins 
from female hepatocytes (20 [Xg vs 2 jig in male) was needed to detect CA III. 
As observed in male cells, maximum S-thiolation was reached at 3 min (lane 
2). Carbonic anhydrase III was thereafter re-reduced to its native status by 15 
min (lane 4), and only one partially S-thiolated form of CA III could be 
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detected in females. When female cells were treated with 0.2 mM menadione 
(data not shown), results similar to male hepatocytes were also obtained. 
Moreover, the nonreducible form of CA HI was also detected in untreated and 
menadione-treated hepatocytes from female rats. 
To demonstrate the applicability of this new method in detecting S-
thiolation of CA HI in other tissues than liver, heart and hind-limb skeletal 
muscle were also tested (Fig. 7). To compensate for the much lower CA HI 
content in cardiac tissue than in liver and skeletal muscle, 25 times more 
cardiac protein was applied to gels (50 \xg vs 2 |ig). As results indicated, a 
modification pattern similar to liver was found in these two tissues after 
treatment with either 20 mM GSSG alone or 20 mM GSSG and 30 mM DTT. 
Reduced CA HI was modified to fully and partially S-thiolated forms by 
GSSG (Fig. 7, lane 2) and this modification was reducible by DTT (Fig 7, lane 
3). An extra band between the partially S-thiolated and reduced CA III was 
found in cardiac tissue but not in liver or muscle samples. By combining lEF 
and SDS-PAGE, as described previously, 30 kDa was also found to be the 
molecular weight of protein in this extra band (data not shown). 
Based on observations that protein in this extra band was not S-
thiolatable, had the same molecular weight as CA III, and was only detectable 
in the heart sample where much higher amounts of total soluble protein was 
loaded on gels, this protein might be another CA isoform that originated from 
blood. Thus, samples prepared from different sources; nonperfused heart, 
perfused heart, and whole blood were compared (Fig. 8). As indicated, this 
extra band was observed in nonperfused heart (arrow in right) (lane 4) but not 
in perfused heart (lanes 1-3). Furthermore, an lEFAVestern blot of blood (Fig. 
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8, lanes 5-7) indicates that the only band detected in these samples is at the 
same position as the extra band in nonperfused heart. Based on the findings 
that this extra protein has the same molecular weight as CA III and could only 
be identified in nonperfused heart and in blood (but not serum, data not 
shown), this extra immunoreactive protein found in nonperfused heart is from 
blood and it is probably CA I (the major CA isoform in red blood cells). 
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DISCUSSION 
Several methods have been used to detect protein S-thiolation, such as 
sodium borohydride reduction of proteins and measurement of the release of 
protein-bound GSH (27), or isoelectric focusing analysis to detect the 
migration of S-thiolated proteins (25), or a radioisotope-based method which 
examines radioactive protein bands on an autoradiogram (17). However, 
these methods are limited in specificity, sensitivity, and/or applicability in 
vivo. Thus, a method that can overcome these limitations may provide a 
powerful tool in studying protein S-thiolation. Immunostaining and Western 
blotting of lEF gels, which has the advantages of lEF analysis in separating S-
thiolated proteins from their parent molecules and the sensitivity/specificity of 
immunostaining, may prove to be useful. 
To demonstrate that this new method is useful in studying the S-
thiolation of CA III, the specificity and sensitivity of anti-CA III serum was 
tested (Fig. 1). Western blotting of lEF gels was sensitive and specific in 
detecting CA III. Generally, Western blots of SDS-polyacrylamide gels were 
used to detect antibody's specificity and sensitivity against antigens, but 
protein denaturation might affect the interaction between antibody and antigen 
as indicated by Fremont and colleagues (28) who noted that anti-CA III 
antibody crossreacts with CA I or II after denaturation with SDS. Thus, an 
undenatured system, lEF/Western blotting maybe useful in examining CA III 
expressing cross-reactivity and specificity of anti-CA III antibody which was 
assayed on Western blots of SDS-polyacrylamide gels. 
As reported by Rokutan et al. (29), who detected protein S-thiolation in 
Coomassie blue-stained lEF gels after incubation with GSSG, CA III was the 
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major S-thiolatable protein in rat liver cytosol. The pattern and extent of CA 
ni S-thiolation was similar to the present results (Fig. 2 and 3A) which 
indicates the ability of this new method to study CA in S-thiolation under 
oxidative stress. Moreover, in the liver homogenates, a second partially S-
thiolated CA HI, similar to a form detected in purified S-thiolated CA HI, was 
detectable by this new method but not by other currently used methods, such 
as Coomassie blue staining (29) or a radioisotope-based method (personal 
communication with Y.-C. Chai). Different S-thiolated fomis of CA III can 
be separated by isoelectric focusing. With subsequent Western blotting and 
immunodetection, modification of CA III under oxidative stress is readily 
detectable. This method may be useful in detecting subtle modifications of 
other proteins which can be electrofocused, if specific antibodies are 
available. 
The differences in the time courses of S-thiolation by t-butyl 
hydroperoxide or menadione (Fig. 3) suggest that different mechanisms are 
involved in S-thiolation and/or dethiolation of CA III in hepatocytes 
stimulated by these two oxidative stressors. t-Butyl hydroperoxide is known 
to be metabolized in liver by GSH peroxidase which oxidizes GSH to GSSG. 
The GSSG produced is converted back to GSH by GSH reductase with the 
consumption of NADPH (30). This increase in GSSG production during t-
butyl hydroperoxide treatment may permit the induction of S-thiolation by the 
mechanism of thiol/disulfide exchange. For menadione, the oxidation of GSH 
to GSSG which accompanies the detoxification of H2O2, (one of the reactive 
oxygen species formed in redox cycling), by GSH peroxidase increases GSSG 
(Table 1). This increase in GSSG, as we observed with both t-butyl 
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hydroperoxide and menadione, was associated with induction of CA ni S-
thiolation (Table 1). This suggests that S-thiolation may be mediated by 
mixed disulfide exchange. However, other reactive oxygen species which are 
generated in the metabolism of either t-butyl hydroperoxide or menadione by 
the cytochrome P450 system (31,32) may also be involved directly in protein 
S-thiolation. As proposed by Thomas et al. (33), either thiol/disulfide 
exchange with GSSG, or an oxyradical-initiated process which generates 
protein thiyl that can then react with reduced GSH, are the major possible 
mechanisms of protein S-thiolation. S-thiolation of CA III, cardiac creatine 
kinase and skeletal muscle glycogen phosphorylase b initiated by reactive 
oxygen species has been reported (4,8). In macrophages, protein S-thiolation 
also can be stimulated by phorbol diester, but with no increase in GSSG level 
(34). But, the relative contribution of these two mechanisms to protein S-
thiolation is uncertain, and may vary with the relative rates of production of 
GSSG and pardally reduced oxygen species. 
Other reactions caused by menadione that are involved in cytotoxicity, 
such as alkylation and GSH conjugation (35,36) may also play some roles in 
protein S-thiolation but their significance is not clear. The inhibitory effect of 
menadione on other antioxidant enzymes, such as GSH reductase, as reported 
by Bellomo et al. (27), might also affect protein S-thiolation. Glutathione 
reductase in isolated rat hepatocytes is inhibited by menadione in a dose- and 
time-dependent manner, thus blocking GSH regeneration and thereby causing 
the accumulation of GSSG. This might explain the difference in GSH status 
in menadione- and t-butyl hydroperoxide-treated hepatocytes and might also 
partly explain the different effects of these two chemicals on protein S-
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thiolation. 
The effects of t-butyl hydroperoxide and menadione on the dethiolation 
process may also provide another possible explanation of different effects on 
CA in S-thiolation. Three mechanisms have been proposed to participate in 
the dethiolation process (5,9,11). These include two enzymatic and one 
nonenzymatic reaction. Enzymatic dethiolation is dependent upon 
thioredoxin-like proteins or glutaredoxin-like proteins. These enzymes have 
been termed dethiolases (11). The nonenzymatic reaction is dethiolation 
through reaction between GSH and protein-SG (thiol/disulfide exchange). 
The two enzymatic mechanisms are more effective in dethiolation of S-
thiolated rat liver CA III (5). Thus, the different effects of menadione and t-
butyl hydroperoxide on the extent of CA III S-thiolation may be due to their 
different regulatory effects on dethiolation. To answer this possibility, more 
definitive studies are ongoing. 
As proposed (5), CA III which focused at the partially S-thiolated band 
is the modified form that reacts with one glutathione molecule and is reducible 
by DTT. However, we found that a portion of the protein in this band was not 
reducible with DTT treatment (Fig. 4). Is this nonreducible protein ÇA III or 
other proteins, such as other CA isoforms? Two pieces of evidence strongly 
suggest that this nonreducible protein is CA III but in another modified state. 
First, either immunostaining (Fig. 5A) or silver staining (Fig. 5B) indicated 
that both reducible and nonreducible forms have the same molecular weight 
(30 kDa). Second, both reducible and nonreducible protein have similar anti-
CA III antiserum binding reactivity as seen by comparing the relative band 
intensity of lanes 1 and 2 with lanes 3 and 4 (Fig. 5). The other CA isoforms 
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have weaker antibody reactivity (5-10%) than CA in (Fig. 1), thus much more 
of the other CA isoforms should be observed in lanes 3 than 4 if similar band 
intensities were observed in lanes 1 and 2. What molecular form of CA in 
would have a pi similar to the S-thiolated form? One hypothesis is that this 
nonreducible protein is another oxidized form of CA III. Sulfonation (adding 
SO3" to SH) could give this oxidized form the same net charge as 
glutathionated CA III. Perhaps this modification occurs not only in cultured 
hepatocytes but in vivo as well. 
With the help of tiiis new lEFAVestern blot method, the detection of S-
thiolated proteins in untreated hepatocytes cultured for 48 h provides strong 
evidence that S-thiolation can occur endogenously in hepatocytes without the 
presence of exogenous oxidative stressors (left lane in Fig. 3B and C). The 
existence of non-reducible forms of CA III in both untreated and menadione-
treated hepatocytes (Fig. 4) also provides the opportunity to explore the nature 
and origin of these molecular forms of the enzyme. It remains to be proven 
that these bands are carbonic anhydrase in, but their detection with anti-CA 
ni serum strongly suggests that they are CA III. 
In spite of the greatly different amounts of CA III in male and female 
hepatocytes (14,15), CA III is equally susceptible to oxidative modification in 
both sexes when treated with t-butyl hydroperoxide or menadione (Fig. 3B 
and 6). The specific role of CA III S-thiolation in oxidative stress is not clear. 
However, based on its abundance in male rat liver and on its 
thiolation/dethiolation (5,8), CA III may act as a substantial pool of reactive 
sulfhydryls that function as an oxyradical scavenger to sequester harmful 
intermediates tiiat are produced in cells. By image analysis, data from a 
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radioisotope-based method showed that 45% of total S-thiolation in 
menadione-treated male hepatocytes could be accounted for by S-thiolated CA 
ni (Y-C. Chai, unpublished data). In addition to its carbon dioxide hydration 
activity, CA in may act as a part of the oxidative stress defense mechanism. 
Regarding the modification pattern of CA III (Fig. 2 and 3), there are 
two reactive sulfhydryl groups present in this protein, and one is more reactive 
than the other. This observation confirms the report by Chai et. al. (5). 
Because one molecule of GSH binding to CA III gives CA III a net of one 
more negative charge, theoretically, Si-SG and S2-SG forms of CA III (Si 
represents the more reactive sulfhydryl group and S2 represents the less 
reactive one) should have the same net charge and focus at the same position. 
However, a slight difference in position was observed in focusing these two 
partially S-thiolated forms of CA III. It is assumed that the addition of these 
two S-thiolatable sites have different effects on protein conformation and so 
affect their relative migration on lEF gel. Conformation may affect protein 
migration on lEF as has been seen with another protein, phosphorylase b. 
Although S-thiolated phosphorylase b is altered by the same net charge of -1 
as partially S-thiolated CA III, the migration of S-thiolated phosphorylase b is 
much less than the migration of partially S-thiolated CA III (4). 
Many tissues other than liver, such as heart, aie of interest in their 
response to oxidative stress. Heart is known to be one of the tissues most 
susceptible to oxidative damage, which may result from reperfusion injury 
(37), chemical toxicity (38,39) or inflammation (40). As reported by Hartz et 
al. (41), several cellular antioxidant enzymes, with the exception of 
glutathione peroxidase, are present in relatively small amounts in heait 
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compared with liver, such as superoxide dismutase and catalase. It is, 
therefore, interesting to know to what extent protein S-thiolation also may 
occur in heart under oxidative stress. CA III S-thiolation was induced in the 
heart and muscle in the presence of GSSG (Fig. 7). Other than CA in, several 
proteins such as creatine kinase and glycogen phosphorylase b (reported as a 
97 kDa protein) have also been observed to be S-thiolated in cultured rat and 
bovine heart cells treated with t-butyl hydroperoxide or diamide (16,42), 
These findings strongly suggest that S-thiolation is one of the major protein 
modifications in heart and in other tissues during oxidative stress. 
Comparing the immunoreactive bands detected by the method described 
here with the previously proposed model (5), data strongly suggest that the 
combination of lEF and Western blotting makes it possible to assess the S-
thiolation status of CA III in intact cells and tissues. The combination of lEF 
and immunoblotting has a greater sensitivity, detecting as little as 10 ng of 
protein. It is many fold more sensitive than other currently used methods, 
such as lEF/Coomassie blue staining or radioisotope-based methods. All the 
possible S-thiolated forms as well as other isoelectric valiants and the relative 
amounts of each form were detectable by Western blotting of lEF gels. No 
protein synthesis inhibitors, such as cycloheximide, aie required for 
lEFAVestern blot determination of protein S-thiolation. Cycloheximide 
pretreatment of cells was necessary for the radioisotope based method (17). In 
some circumstances cycloheximide may be toxic to cells and thus interferes 
with the interpretation of results. lEFAVestern blot is also time-saving in 
comparison with the radioisotope-based method (17). lEFAVestern blotting is 
applicable to experiments with whole animals because no pretreatment with 
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cycloheximide is required. Thus, considering sensitivity and applicability in 
vivo, this method may be used to detect subtle changes in the protein S-
thiolation of other proteins, once a specific antibody can be raised. 
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Figure 1. Specificity of CA III antiserum on Western blots of both isoelectric 
focusing (lEF) and SDS polyacrylamide gels 
lEF and Western blot were carried out as described in Materials and 
Methods. (A) The focusing of CA isoforms on Coomassie blue-
stained lEF gel. Two |ig of each isoform were applied to gel. Lanes 
from left to right show 1) Human erythrocytes CA I (hCA I), 2) 
Human Erythrocyte CA in (hCA II), 3) Bovine erythrocyte CA n 
(bCA II), 4) Reduced CA III from rat liver. (B) Immunostaining of 
CA isoforms on a Western blot of an lEF gel. Two different 
amounts of each isoform were loaded on the gel with 10 or 20 ng of 
CA ni and 20 or 400 ng each of other isoforms. (C) 
Immunostaining of CA isoforms on a Western blot of a SDS-
polyacrylamide gel. 20 or 400 ng of CA III, or 400 ng of each 
isoform were applied to SDS-polyacrylamide gel. 
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Figure 2. Pattern of CA III S-thiolation on Coomassie-blue stained isoelectric 
focusing gel 
S-Thiolation and lEF were performed as described in Materials and 
Methods. In each sample, 2 jig of purified CA in or 80 |ig of total 
soluble protein from liver homogenates were applied to gels, 
respectively. Lanes 1 and 2 show the position of purified CA in 
before and after incubated with 20 mM GSSG at 30°C for 30 min. 
Lanes 3 to 5 show the migration of CA III bands in liver 
homogenate. Lane 3 shows the untreated homogenates. Lane 4 
shows the homogenate treated with 20 mM GSSG at 30*^C for 30 
min. Lane 5 shows the homogenate treated with GSSG followed by 
treatment with 30 mM DTT for an additional 30 min. 
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Figure 3. Western blotting of lEF gels in detecting the extent of S-thiolation 
of CA in in male rat hepatocytes treated with either t-butyl 
hydroperoxide or menadione 
S-thiolation was analyzed as described in Materials and Methods. 
Two jig soluble protein was applied to an lEF gel in each sample. 
(A) CA in S-thiolation by glutathione disulfide (GSSG). Lane 1 
shows the hepatocyte homogenate treated with GSSG only. Lane 2 
shows the homogenate incubated with 20 mM GSSG at 30°C for 30 
min followed by 30 mM DTT for 30 min. (B) S-thiolation of CA 
in in t-butyl hydroperoxide-treated hepatocytes. Cells cultured for 
48 h were treated with 0.5 mM t-butyl hydroperoxide at 37"C for 
the time indicated. (C) S-thiolation of CA in in menadione-treated 
hepatocytes. S-thiolation of CA in was stimulated by treating 
hepatocytes after 48 h in culture with 0.2 mM menadione at 37°C 
for the time indicated. 
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Table 1. The effects of t-butyl hydroperoxide and menadione on 
intracellular hepatic GSH^ 
Tôteî GSH/GSSG 
Time n GSH GSSG Glutathione Ratio 
min nmole/mg protein 
0 9 40.5 ±2.38^ 1.24 ±0.16^ 43.0 + 2.35^ 33.1 ±2.35^ 
t-Butyl hydroperoxide (0.5 mM) 
3 3 12.7 ±0.65^ 13.4 ±1.02^^ 41.4 ±2.27^ 0.95 ±0.08^ 
9 3 27.7 ±1.07^ 7.61 ±2.40^ 42.8 ±3.70^ 3.92 ±1.38^ 
15 3 32.4 ±1.58® 3.53 ±1.12® 39.5 ± 3.75^^ 9.70 ±2.40® 
Menadione (0.2 mM) 
7 4 4.30 ±1.22^ 14.9 ±0.95^ 34.2 ±2.02^ 0.29 ±0.09^ 
15 4 1.96 ±0.998 11.1 + 1.79^ 24.2 ± 3.29^ 0.19±0.11^ 
^Data are expressed as mean ± standard deviations. 
bcdefgTreatments not sharing a letter are significantly different, 
p<0.05, Student t-test. 
Figure 4. Nonreducible form of CA III in menadione-treated hepatocvtes 
Hepatocytes cultured for 48 h were either untreated or treated with 
0.2 mM menadione for 10 min at 37°C. Samples were analyzed by 
lEFAVestem blotting as described in Materials and Methods. In 
each sample, 2 jig soluble protein was applied to the gel. The left 
two lanes (lanes 1 and 2) show untreated hepatocytes and the right 
two lanes (lanes 3 and 4) from menadione-treated hepatocytes. 
Samples in lane 2 and 4 were prepared in the presence of 30 mM 
DTT to reduce S-thiolated CA III. 
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Figure 5 Comparison of molecular weight and immunoreactivity of reducible 
and nonreducible CA HI by SDS-PAGE and by SDS-
PAGEAVestem blotting analysis 
The diagram shows methods used for molecular weight and 
immunoreactivity determination of these two proteins. Liver 
homogenates were treated with 20 mM GSSG to generate S-
thiolated CA HI (lanes 1 -4), then lanes 1 and 4 were treated with 30 
mM DTT to produce nonreducible CA III. Amounts of protein as 
indicated were applied to lEF gels. Five fold greater amounts of 
protein were loaded on gels from DTT-treated samples than from 
samples without DTT, in order to readily compare the amount of 
nonreducible CA in among samples. After electrofocusing, bands 
that contained either reducible or nonreducible CA III were cut out 
and applied to an SDS-polyacrylamide gel. After electrophoresis, 
lanes 1 and 2 were blotted to a membrane, lanes 3 and 4 were used 
for silver staining. (A) shows the immunoblotting of lanes 1 and 2. 
(B) shows the silver staining of lanes 3 and 4 from SDS-
polyacrylamide gels. Lane 5 contains the molecular weight 
markers. 
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Figure 6. Carbonic anhydrase III S-thiolation in female hepatocytes by t-butyl 
hydroperoxide 
Sample preparation and analysis in lEFAVestern blotting were 
carried out as described in Materials and Methods. In each sample, 
20 |ig of soluble protein was applied to an isoelectric focusing gel. 
Hepatocytes cultured for 48 h were treated with 0.5 mM t-butyl 
hydroperoxide for the times indicated. 
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Figure 7. CA HI S-thiolation in rat liver, heart, and muscle 
Rat liver, heart, and hind leg muscle homogenates were prepared as 
described in Materials and Methods. Samples for the stimulation of 
CA ni S-thiolation with GSSG and for complete reduction of CA 
in with DTT contained no lAM. Two p-g of total soluble proteins 
from liver and hind-limb muscle were applied to the gel and 50 \ig 
of heart protein was loaded. Lane 1 for each tissue shows the 
untreated homogenates. Lane 2 shows the S-thiolated homogenates 
treated with 20 mM GSSG at 37"C for 30 min. Lane 3 shows the 
homogenates treated with 20 mM GSSG followed by treatment with 
30 mM DTT for 30 min. 
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Figure 8. Comparison of CA III S-thiolation in nonperfused heart, perfused 
heart, and whole blood 
Perfused and nonperfused heart homogenates were prepared as 
described in Materials and Methods. 50 jxg of total soluble 
protein/lane was applied to an lEF gel. Blood samples were 
collected from the tail vein with 20 |ig/ml EDTA. Blood was 
sonicated twice for 10 sec to break blood cells. Cell debris was 
separated from blood samples by centrifugation. Samples were 
treated with 20 mM GSSG at 37°C for 30 min. (A) shows CA III 
S-thiolation in perfused heart. (B) shows the CA III S-thiolation 
and all immunoreactive bands in nonperfused heart. (C) shows the 
immunoreactive bands in blood samples. 
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PAPER 2: S-THIOLATION OF CA HI (A THIOLATABLE MARKER 
PROTEIN) IN SELENIUM-DEFICIENT, GLUTATHIONE-
DEPLETED RAT HEPATOCYTES UNDER OXIDATIVE 
STRESS 
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ABSTRACT 
Hepatocytes were prepared by collagenase perfusion from Se-deficient 
and Se-adequate rats. The hepatocytes were treated with the glutathione 
synthesis inhibitor, buthionine sulfoximine (BSO), and oxidative stressors, t-
butyl hydroperoxide or menadione, to examine protein S-thiolation. Carbonic 
anhydrase HI (CA IE) as a marker of thiolation, was measured by isoelectric 
focusingAVestem blotting. Selenium deficiency, which blocks GSH 
peroxidase activity and thus inhibits GSSG formation, suppresses the S-
thiolation of CA HI in isolated rat hepatocytes during treatment with t-butyl 
hydroperoxide or menadione but shows no effect on GSH depletion by BSO. 
BSO, a GSH synthesis inhibitor, depleted GSH in both Se-adequate and Se-
deficient hepatocytes with a similar dose-dependent and time-dependent 
response. In the presence of 2 mM BSO, 5%, and 6% of total intracellular 
GSH remained in Se-adequate and Se-deficient cells, respectively, after 20 h 
exposure. The 0.15 mM of BSO was estimated to cause 50% depletion of 
GSH over a 20 h exposure. Total intracellular GSH and the ratio of GSH to 
GSSG did not differ between Se-adequate and Se-deficient hepatocytes. GSH 
oxidation was markedly depressed in Se-deficient hepatocytes under treatment 
with either 0.5 mM t-butyl hydroperoxide or 0.2 mM menadione. In Se-
adequate hepatocytes, GSSG formation reached a maximum at 3 min and then 
GSSG was gradually reduced to GSH. Whereas, after menadione treatment of 
Se-adequate hepatocytes, intracellular GSSG level increased gradually and 
was not re-reduced to GSH. Significant depletion of total intracellular GSH 
was observed in Se-adequate hepatocytes after treatment with menadione but 
not after treatment with t-butyl hydroperoxide. However, in Se-deficient 
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hepatocytes, GSH depletion was significant after treatment with either t-butyl 
hydroperoxide or menadione. The pattern of CA HI S-thiolation in Se-
adequate hepatocytes was concomitant with the formation of GSSG. S-
thiolation of CA HI by t-butyl hydroperoxide reached a maximum at 3 min 
and decreased to control levels by 15 min, whereas menadione gradually 
increased CA in S-thiolation. S-thiolation of CA III in Se-deficient 
hepatocytes was also detected but to a much lesser extent than observed in Se-
adequate cell. In BSO-treated Se-adequate and Se-deficient hepatocytes, no 
detectable CA III S-thiolation occurred during treatment with either t-butyl 
hydroperoxide or menadione. These findings suggest that protein S-thiolation 
occurred largely by mixed-disulfide exchange in rat hepatocytes under 
oxidative stress. 
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INTRODUCTION 
A mixed-disulfide exchange mechanism in which glutathione disulfide 
(GSSG) reacts with protein sulfhydryl groups to form S-thiolated proteins has 
been suggested as a major mechanism of protein S-thiolation in vivo (1-3), 
based on the observation that there is a strong correlation between the 
GSSG/GSH ratio and the total protein S-thiolation (3,4). However, in vivo, 
GSH may not be oxidized to an extent that permits protein S-thiolation (5). 
Thus an alternative mechanism, an oxyradical-initiated process, has been 
proposed by Thomas et al. (6) to also play an important role in protein S-
thiolation. In this mechanism, protein reactive sulfhydryl groups are capable 
of forming rather stable thiyl radicals in the presence of oxyradicals. These 
protein thiyl radicals then react with reduced GSH to form mixed disulfides. 
In an in vitro enzyme system, creatine kinase, glycogen phosphorylase b, and 
carbonic anhydrase III (CA III) are S-thiolated under conditions such that the 
amount of GSSG present is insufficient to generate protein S-thiolation (7-9). 
The importance of each of these two mechanisms to protein S-thiolation 
may depend on several factors, such as cell type, cellular GSH level, and 
oxidative stressors. Cells, such as hepatocytes, which have large amount of 
cellular GSH may favor thiol-disulfide exchange and macrophages, in which 
the amount of GSH is relatively small, may utilize predominately an 
oxyradical-initiated process. Also, chemicals that cause foiTnation of large 
amounts of glutathione disulfide, such as menadione, may cause protein S-
thiolation primarily by mixed-disulfide exchange. 
S-thiolation represents a physiological mechanism of regulating enzyme 
activity and, thereby of regulating cell metabolism (1,2,10). In recent studies. 
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Thomas et al. (11-13) have proposed that protein S-thiolation, because it is 
readily reversible, may also have a role in protecting proteins from oxidative 
damage, because other oxidized forms of protein sulfhydryls may lead to 
protein degradation. 
Glutathione peroxidase (GSH Px), an important antioxidant enzyme that 
protects cells from oxidative damage, is a selenium-dependent protein (14) 
that utilizes the highly hydrophilic electron donor GSH as a substrate to 
reduce many hydroperoxides to alcohols, accompanied by the production of 
GSSG. The reduction of hydroperoxides formed in cells, such as hydrogen 
peroxide, can prevent their breakdown to reactive oxygen species which alter 
numerous biological processes (15). Hydrogen peroxidase activity varies with 
dietary selenium concentration (16). In animals fed a selenium deficient diet, 
its activity falls to a very low level, usually less than 2% of normal animals. 
Thus, hepatocytes isolated from selenium-deficient rats are useful in studying 
the effect of GSH status on the metabolism and toxicity of drugs and 
chemicals (17,18). Decreased Se-dependent GSH Px activity due to Se-
deficiency may also provide a possible model to study mechanisms of protein 
S-thiolation. Selenium deficiency would be expected to limit the formation of 
GSSG, a product of GSH Px activity. Therefore, if protein S-thiolation 
depends on GSSG-protein mixed disulfide exchange, protein S-thiolation may 
be suppressed in Se deficiency. 
Buthionine sulfoximine (BSO), a GSH synthesis inhibitor, was also 
tested to examine its effects on protein S-thiolation in cultured hepatocytes. If 
GSH is decreased to a very small amount by BSO, BSO may be expected to 
block protein S-thiolation almost completely. 
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Carbonic anhydrase in (CA HI) has been reported as a major S-
thiolatable cytosolic protein in male rat liver (reported as a 30 kDa protein) 
(19). Thereafter, it was purified and identified as CA 111(13). By isoelectric 
focusing analysis (lEF), S-thiolated CA in migrates to two different positions 
on lEF gels, and is proposed to have two reactive sulfhydryls, with one more 
reactive than the other (13). CA HI S-thiolation is also a reversible reaction 
(12,13). Due to its presence in male rat liver in large amounts and its ability 
to focus on lEF gels, CA III is a good choice as a marker of protein S-
thiolation during oxidative stress. 
Isoelectric focusing is a very useful technique in studying proteins 
modified by glutathione S-thiolation (7,13). The addition of glutathione to a 
protein usually changes the protein's net charge at physiological pH by -1 (the 
addition of an NH+3 and a COO" group from glutamate and a COO" from the 
glycine residue of glutathione). Additional glutathione/protein mixed 
disulfides would generate further changes in charge. Thus, each band of 
purified CA IE on an lEF gel represents a different modified form. 
Furthermore, combination of lEF with immunoblotting, which shows 
specificity and sensitivity, provides a valuable tool in studying protein S-
thiolation. 
As a continuation of previous studies on the S-thiolation of carbonic 
anhydrase HI (CA IH) in cultured rat hepatocytes, the extent of CA III S-
thiolation was studied in either Se-adequate or Se-deficient cultured rat 
hepatocytes, also treated with BSO and/or menadione or t-butyl 
hydroperoxide. The extent of BSO's effect on the GSH depletion rate in Se-
adequate and Se-deficiency hepatocytes was examined. A new method which 
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combined isoelectric focusing analysis and immunoblotting was used to detect 
CA in S-thiolation. 
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MATERIALS AND METHODS 
Materials 
Bovine serum albumin (BSA), iodoacetamide (lAM), iodoacetic acid, 
menadione, t-butyl hydroperoxide, phenylmethylsulfonyl fluoride (PMSF), 
benzamidine, and leupeptin were obtained from Sigma Chemical Co. (St. 
Louis, MO). Insulin, transferrin, L-15 medium, and penicillin-streptomycin 
solution were from Gibco Laboratories (Grand Island, NY). Collagenase 
(type I) and Percoll were from Pharmacia LKB (Piscataway, NJ). GelBond 
was from FMC Co. (Rockland, CA). Peroxidase anti-rabbit IgG kit was 
obtained from Vector Laboratories (Burlingame, CA). 
Antibody preparation 
Rat liver CA III was purified as described (13). One hundred jig of 
purified CA HI was injected subcutaneously into a 6 month-old New-Zealand 
male rabbit twice. In the first injection, CA III was mixed 1:1 with Freund's 
complete adjuvant (0.5 ml). Two weeks later, a booster injection of CA III 
mixed 1:1 with Freund's incomplete adjuvant was given (0.5 ml). Antiserum 
was collected by biweekly bleeding from the ear vein beginning 2 weeks after 
the booster injection. Antiserum titration was determined by dot 
immunoassay (20) and a 1:500 titer was used in detecting CA III S-thiolation. 
Animals 
Male Sprague-Dawley rats from Sasco Co. (Omaha, NE),weighing 300-
400 g which had been fed Se-deficient or Se-adequate diets from weaning for 
10 weeks were used for hepatocyte isolation in the following experiments. 
The animals were maintained in stainless grid cages with an artificial 12 h 
light-dark cycle. Rats had free access to diets and distilled deionized water. 
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The Se-defîcient diet was prepared as previously described (16). The control 
diet contained 0.5 mg Se/kg diet supplemented in the form of Na2Se03. 
Selenium deficiency was verified by measuring GSH Px activity in the liver 
cytosolic fraction from rats fed control or selenium-deficient diet. 
Rat hepatocytes were prepared by collagenase perfusion as described by 
Berry and Friend (21), and Bonney et al. (22) with some modifications. Rats 
were anesthetized by intraperitoneal injection with sodium pentobarbital (100 
mg/kg body weight), and then the peritoneal cavity was opened. Liver was 
perfused via the portal vein at a flow rate of 25 ml/min with 150 ml of 25 mM 
sodium phosphate buffer (pH 7.6), containing 3.1 mM KCl, 119 mM NaCl, 
5.5 mM glucose, 0.1% BSA, and 0.0005% phenol red, to remove blood (23). 
Then, the buffer was replaced by 200 ml of the same buffer supplemented 
with 70 mg collagenase, 40 mM CaCl], and 5 mg trypsin inhibitor and the 
liver was perfused for another 8 min at the rate of 18 ml/min. To produce a 
single-cell suspension, liver was then removed and sieved through a nylon 
mesh by washing with L-15 medium (pH 7.6), supplemented with 18 mM 
HEPES, 0.2% BSA, 0.05% glucose and 5 jJ.g/ml insulin. The cell suspension 
was centrifuged for 3 min at 200 rpm (International Equipment Company, lEC 
EXP centrifuge, Needhorm Heights, MA) and the cells were resuspended with 
washing medium and centrifuged again. After washing, 25 ml of cell 
suspension was gently mixed with 2.4 ml lOX Hank's buffer plus 21.6 ml 
Percoll and centrifuged at 500 rpm for 10 min. The Percoll gradient separates 
dead and nonparenchymal cells from the hepatocytes (24). Hepatocytes were 
then resuspended and washed twice with washing medium. Cell viability was 
determined by trypan blue exclusion and was greater than 90%. 
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After final washing, the isolated hepatocytes were resuspended in L-15 
cell culture medium (pH 7.6), supplemented with 18 mM HEPES, 0.2% BSA, 
5 jig/ml each of insulin, and transferrin, 5 mg/ml galactose, 1 uM 
dexamethasone, 100 lU/ml penicillin, and 100 |ig/ml streptomycin, at a final 
cell density of 0.5x10^ cells/ml. Hepatocytes isolated from control rats were 
also cultured in the same medium containing 5 ng/ml Na2Se03. 2.5x10^ cells 
were plated on each 60 mm collagen-precoated plastic tissue culture dish 
(Fisher Scientific Company, Chicago, IL) and incubated in a 37°C humidified 
incubator in an air atmosphere. The cell culture medium was changed 4 h 
after plating. Treatment of hepatocytes with BSO was started when the 
medium was changed. 
At 24 h after plating, the hepatocytes were switched to L-15 medium 
(pH 7.6), contained 18 mM HEPES. For 15 min, cells were either treated with 
0.2 mM menadione or 0.5 mM t-butyl hydroperoxide (personal 
communication with Y.-C. Chai), The reaction was stopped by removing 
medium and washing with cold PBS. Cells were scraped with a rubber 
policeman in 100 |il of cold sample buffer, pH 7.4, containing 20 mM 
HEPES, 5 mM EDTA, 5 mM EGTA, 1 mM PMSF, 1 mM benzamidine, 5 
ng/ml leupeptine, and 50 mM iodoacetamide (lAM). Cell homogenates were 
prepared by centrifugation at 10,000 xg for 15 min at 40C and pai ticulate-free 
extracts were used for isoelectric focusing analysis. Homogenates were kept 
on ice while protein concentration was determined by the method of Lowry et 
al (25). Samples for complete reduction of hepatocellular proteins with 
dithiothreitol (DTT) contained no lAM. Samples for GSH and GSSG assay 
were prepared by adding 1 ml 5% perchloric acid, containing 2 mM 
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phenanthroline, to each dish. Then the acid soluble GSHand GSSG were 
measured by HPLC (26). Glutathione peroxidase was determined as 
described by Lawrence and Burk (27). 
Analysis of protein S-thiolation 
CA in S-thiolation was analyzed by thin-gel isoelectric focusing 
analysis (28) and Western blotting. Cell extracts containing equal amount of 
proteins were applied to 0.8 mm gels which contained 4% acrylamide (4% T-
2.6% C acrylamide ) and 2% LKB ampholytes in a mixture of 5 parts 
preblended pH 5-8 to 1 part pH 4-6 ampholyte. For transferring proteins to 
nitrocellulose membrane after electrofocusing, lEF gels were made on NetPix 
(Serva Biochemical Inc., Westbury, NY), a mesh backing that stabilizes the 
gels during separation from the GelBond and transfer to the Western blotting 
transfer chamber. Gels were prefocused for 10 min before sample loading and 
samples were focused for 50 min at 4° C at a voltage limited to 1,500 v and a 
limited current and power of 2.75 mA/cm and 1.125 w/cm gel width, 
respectively. 
Western blotting was performed as described (29) with modifications. 
Cold 0.7% acetic acid solution was used as transfer buffer to achieve a good 
efficiency in blotting proteins from lEF gels to nitrocellulose membrane. 
After electrofocusing, the thin-gel which was supported by NetFix was 
separated from GelBond and transfer into cold 0.7% acetic acid solution 
immediately. Gels were packed as described (29) and blotted at a constant 
voltage of 100 v for 2 h. In contrast to the well-known blotting system for 
SDS-PAGE gels, proteins have a net positive charge in this acidic blotting 
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buffer, thus, the output from the power supply was reversed. Ice-cold blotting 
buffer was required for efficient blotting. 
The nitrocellulose membrane was immunostained with the anti-CA IE 
antiserum and the peroxidase anti-rabbit IgG kit as described (20) with some 
modifications. One-hour incubations with blocking buffer, primary antibody, 
secondary antibody, and avidin-peroxidase complex were performed at 37 °C. 
For color development, 0.012% H2O2 and 0.01% 3,3'-diaminobenzidine were 
used as peroxidase substrates. Membranes were analyzed by image analysis 
to quantitate the extent of modification of CA III between Se-adequate, Se-
deficient, and BSO-treated hepatocytes during oxidative stress. The analysis 
was done by a Zeiss SEM-IPS image analysis system (Zeiss-Kontron, IBAS 
version 2.00), and all of the integrated peak areas were normalized by a 
standard curve obtained from known amounts of purified CA III. 
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RESULTS 
The decrease in total GSH (GSH and GSSG) was found to be related to 
the concentration of BSO to which the hepatocytes were exposed for 20 h 
(Table 1 and Fig. 1). At a BSO concentration of 0.25 mM, the cellular total 
GSH level in Se-adequate hepatocyte was 21% of control. When BSO 
concentration was increased to 6 mM, only 3% of total GSH remained after 20 
h exposure. Intracellular GSH synthesis inhibition by BSO in hepatocytes 
isolated from rats fed a Se-deficient diet for 8 weeks and cultured in Se-free 
medium (Table 1, Fig. 1) produced a response similar to Se-adequate 
hepatocytes. The BSO concentration which gave 50% inhibition of GSH 
synthesis after 20 h of treatment was estimated to be 0.15 mM. 
The reduction of total GSH in cultured rat hepatocytes by 2 mM BSO 
was shown to be time-dependent (Table 2, Fig. 2). In Se-adequate 
hepatocytes, after 5 h exposure, the total intracellular GSH level was 41% of 
the amount at time 0. As the time of exposure increased, a further decrease in 
intracellular GSH was observed. After 20 h of BSO exposure, only 6% of the 
GSH remained. The GSH levels in cultured rat hepatocytes were not constant 
during culture (Table 2). Thus, each calculation of GSH content in BSO-
treated hepatocytes was expressed as a proportion of GSH in control cells held 
for the same length of time. As with the dose-dependence of BSO, the time-
course of GSH synthesis inhibition by 2.0 mM BSO was also found to be 
similar in Se-adequate and Se-deficient hepatocytes (Table 2, Fig. 2). The 
concentration of total GSH varied with culture time and was significantly 
greater at 24 h than at 4 h after plating. The increase of GSH in Se-deficient 
hepatocytes during the first 24 h in culture was much slower than that found in 
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Se-adequate hepatocytes. Moreover, the difference of total GSH level 
between Se-adequate and Se-deficient hepatocytes increased when those cells 
were cultured beyond 24 h. After 48 h culture, the intracellular total GSH 
content in Se-adequate hepatocytes was 47.8±4.9 nmol/mg protein, but was 
only 33.2±8.6 nmol/mg protein in Se-deficient hepatocytes, (p<0.05). 
GSH changed in Se-adequate hepatocytes in response to 0.5 mM t-butyl 
hydroperoxide or 0.2 mM menadione (Table 3). The maximum formation of 
GSSG was reached at 3 min after t-butyl hydroperoxide was introduced, and 
then declined gradually. Total GSH was less at 15 min after t-butyl 
hydroperoxide treatment but was not significantly different from control 
hepatocytes (p<0.05). The ratio of GSH to GSSG decreased from 27.9 to 1.2 
at 3 min and increased to 8.9 after 15 min of t-butyl hydroperoxide treatment. 
After menadione treatment, however, once reduced GSH was oxidized to 
GSSG, the intracellular concentration of GSSG remained great. The major 
portion of the decrease in reduced GSH could be accounted for in the 
formation of GSSG but there was a 30% loss of total GSH. The total amount 
of GSH in cells treated with menadione for 5 min was only 70% that of 
untreated hepatocytes. A slight increase in GSH depletion was observed after 
10 min menadione treatment as compared with 5 min menadione treatment but 
the difference was not significant. The ratio of GSH to GSSG was markedly 
decreased by menadione. 
The oxidation of GSH to GSSG in metabolizing the t-butyl 
hydroperoxide and menadione is catalyzed by GSH peroxidase with the 
consumption of NADPH. The activity of GSH Px in Se-deficient hepatocytes 
with H2O2 as a substrate was markedly depressed to 1.0±0.4 |imole 
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NADPH/(min-mg protein) as compared with 166±29 jimole NADPH/(min-mg 
protein) in Se-adequate cells. Such a decline in GSH Px activity permitted no 
GSH oxidation in t-butyl hydroperoxide treated Se-deficient hepatocytes over 
time (Table 4). An increase in GSSG in menadione treated Se-deficient cells 
was observed but the amount of GSSG formed was much less than that 
produced in Se-adequate cells. In contrast with Se-adequate hepatocytes, total 
GSH concentration was significantly less in both t-butyl hydroperoxide- and 
menadione-treated Se-deficient hepatocytes (Figs. 3,4) suggesting that the Se-
deficient hepatocytes are more susceptible to oxidative stress than are Se-
adequate hepatocytes. 
After exposure to 2 mM BSO for 20 h, only 5% and 6% of the GSH 
remained in Se-adequate and Se-deficient hepatocytes, respectively, compared 
with untreated cells. Even with the small amount of GSH present in BSO-
treated hepatocytes, the effect of t-butyl hydroperoxide or menadione on GSH 
was similar to that observed in cells not treated with BSO (Table 5 and 6). 
Significant formation of GSSG due to t-butyl hydroperoxide or menadione 
occurred in Se-adequate hepatocytes and not in Se-deficient hepatocytes. 
Depletion of GSH was also observed in Se-adequate and Se-deficient BSO-
treated cells by treating with either t-butyl hydroperoxide or menadione. 
By combining lEF analysis and immunoblotting technique, different S-
thiolated forms of CA III could be detected (Figure 5 and 6). In the Se-
adequate hepatocytes (Figure 5A), significant production of S-thiolated CA III 
was stimulated by menadione and this modification gradually increased over 
time (lanes c and e). In the presence of DTT, this modification was reversed 
to its reduced form (lanes d and f), which confirmed that this modification was 
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due to disulfide bond formation on proteins. In contrast to the effects of 
menadione, CA in S-thiolation by t-butyl hydroperoxide was readily reversed. 
S-thiolation of CA in reached a maximum at 3 min (lane g) and decreased 
gradually to its original status at 15 min (lane j). This formation of modified 
CA in by t-butyl hydroperoxide was also reversible in the presence of DTT 
(lane h). In examining the extent of CA III S-thiolation by menadione or t-
butyl hydroperoxide and the changes of GSH status (Table 3), S-thiolation of 
CA in was concomitant with changes in hepatic GSH and GSSG levels. 
In Se-deficient hepatocytes, there was less than 1 % of GSH Px activity 
remained as compared with that in Se-adequate hepatocytes. During treatment 
of the Se-deficient hepatocytes with either t-butyl hydroperoxide or 
menadione, S-thiolation of CA ni was markedly decreased (Fig. 5B) 
compared with the Se-adequate hepatocytes (Fig. 5A). In both BSO-treated 
Se-adequate and Se-deficient hepatocytes, there was no detectable CA III S-
thiolation (Fig. 6A and B). However, in all Se-deficient and in menadione-
treated Se-adequate hepatocytes treated with BSO, an iixeversibly modified 
form of CA III which migrated at the same position as partially S-thiolated 
CA in was present. 
With image analysis, the increase in band intensity of the partially and 
fully S-thiolated forms by either t-butyl hydroperoxide or menadione over 
time was estimated with untreated cells as a control (Table 7). Formation of 
both partially and fully S-thiolated CA III was stimulated in Se-adequate 
hepatocytes by either stressor, but only partially S-thiolated CA III could be 
detected in Se-deficient cells. In Se-adequate cells, the significant increase 
(p<0.05) of partially and fully S-thiolated CA III was observed at 3 and 9 min 
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after t-butyl hydroperoxide treatment and at 5 and 10 min after menadione 
treatment. After 15 min of t-butyl hydroperoxide incubation, the amount of 
either pardally or fully S-thiolated CA in closely resembled the original state. 
However, with menadione treatment, the amount of S-thiolated CA III 
continued to increase. At 10 min the amount of total S-thiolated CA III was 
greater than that detected at 5 min but the difference was not significant. The 
occurrence of CA III S-thiolation was also detected in Se-deficient 
hepatocytes but to a much lesser extent. The only significant formation of 
partially S-thiolated CA III was found after 3 min of t-butyl hydroperoxide 
and after 10 min of menadione treatment. 
Total S-thiolated CA III increased in both Se-adequate and Se-deficient 
cells during treatment with either t-butyl hydroperoxide or menadione (Fig. 7 
and 8). In Se-adequate hepatocytes, total S-thiolated CA III was increased 
significantly (p<0.05) at 3 min after t-butyl hydroperoxide treatment, and then 
the amount declined gradually. After 15 min of t-butyl hydroperoxide 
incubation, total S-thiolated CA III did not differ from untreated controls (Fig. 
7). Total S-thiolated CA III in Se-deficient hepatocytes after t-butyl 
hydroperoxide treatment was much less than that in Se-adequate cells. A 
significant increase in total S-thiolated CA III in those Se-deficient 
hepatocytes was observed at 3 min (Fig. 7). During treatment with 
menadione, the formation of total S-thiolated CA III was markedly stimulated 
in Se-adequate hepatocytes and S-thiolation continued to increase from 5 to 10 
min after treatment (Fig. 8). The effect of menadione on CA III S-thiolation 
in Se-deficient hepatocytes, as seen with t-butyl hydroperoxide treatment, was 
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significantly depressed. Increased CA in S-thiolation in Se-deficient 
hepatocytes was observed at 10 min after menadione treatment (Fig. 8). 
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DISCUSSION 
Mixed-disulfide exchange (1,2) or oxyradical-initiated processes (6) are 
currently proposed to be the mechanisms of protein S-thiolation, based on 
evidence that S-thiolation was positively correlated with the generation of 
GSSG (3,4) or S-thiolation could be initiated under circumstances that caused 
no detectable change in GSSG production (7-9). Thus, increased GSSG 
formation is required for S-thiolation through mixed-disulfide exchange. 
Inhibiting GSH Px activity, thus blocking GSSG generation in Se-deficient 
hepatocytes can be used to distinguish whether a mixed-disulfide or an 
oxyradical-initiated process is the major mechanism of protein S-thiolation. 
Menadione and t-butyl hydroperoxide cause GSSG formation and are also 
capable of generating reactive oxygen species in hepatocytes. They are, 
therefore, good model chemicals in this study. On the basis of the millimolar 
concentration of GSH in rat liver (30), GSH level may be an important factor 
in the formation of protein S-thiolation in liver. When GSH was depleted to a 
very low level by BSO, protein S-thiolation was suppressed almost 
completely. In the present study, mixed-disulfide exchange is much more 
important than an oxyradical-initiated process in CA III S-thiolation in rat 
hepatocytes under treatment with t-butyl hydroperoxide or menadione. 
Buthionine sulfoximine is a selective inhibitor of 7-glutamylcysteine 
synthetase which acts in the first step also the committed step in the GSH 
synthesis (31). It is relatively nontoxic to animals and effective in depleting 
intracellular GSH level. Glutathione, which is present in millimolar amount in 
liver (30), has been known to play a very important role in hepatic 
detoxification and xenobiotic metabolism, by removal of reactive oxygen 
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intermediates. Hepatocytes have been widely used as a model in the study of 
drug metabolism and toxicity of a variety of chemicals (32). It is of interest to 
know whether hepatocytes, including Se-adequate and Se-deficient 
hepatocytes, are particularly sensitive to the potential toxic effects of GSH 
depletion by BSO. In this study, GSH depletion in cultured rat hepatocytes by 
BSO was dose- and time-dependent (Fig. 1,2, Table 1,2). The effective 
concentration (EC50) of BSO in depleting hepatic intracellular GSH 50% 
within 20 h was 0.15 mM and the required exposure time for 50% GSH 
depletion by 2 mM BSO was 4 h. These results indicated that the primary 
cultures of hepatocytes were effectively depleted of their GSH by BSO. The 
depletion rate was in agreement with the report of Orrenius et al. (33) who 
indicated that the biological half-life of GSH in rat hepatocytes is 3-5 h. The 
dose- and time-dependence of response to BSO was similar in Se-adequate 
and Se-deficient hepatocytes (Fig. 1,2). 
In Se-deficient hepatocytes, GSH metabolism differs from Se-adequate 
hepatocytes (17). According to the reports of Burk et al. (17,34), in addition 
to GSH Px, other GSH-dependent enzymes were also affected by Se-
deficiency, thus influencing GSH synthesis and turnover. In isolated Se-
deficient hepatocytes over a 5 h incubation, a much higher intracellular GSH 
concentration was observed as compared with the Se-adequate hepatocytes. y-
Glutamylcysteine synthetase activity was 8.4 and 4.5 nmole/(mg protein min) 
in Se-deficient and Se-adequate hepatocytes, respectively. In the present 
study, there was no difference in hepatic intracellular total GSH between Se-
deficient and Se-adequate cells during the first 9 h after plating (Table 2). 
Beyond 9 h after plating, the total GSH concentration in both Se-adequate and 
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Se-deficient hepatocytes increased gradually but the increase was much faster 
in Se-adequate than in Se-deficient cells. Moreover, the total intracellular 
GSH in Se-adequate hepatocytes increased continuously up to 48 h after 
plating, but the GSH level of Se-deficient hepatocytes remained the same at 
48 h as at 24 h after plating (Table 2). Se status significantly affects 
hepatocyte GSH metabolism in cells cultured beyond 24 h. Se-deficient 
hepatocytes were more susceptible to damage during culture than Se-adequate 
hepatocytes, as seen in the increased amount of irreversible modified CA III 
(Fig. 5,6). 
S-thiolation of CA III in Se-adequate and Se-deficient hepatocytes 
during treatment with t-butyl hydroperoxide or menadione (Fig. 5A) was 
concomitant with increased GSSG (Table 3,4). This observation strongly 
suggests that protein S-thiolation occurs in these cells primarily by mixed-
disulfide exchange. The positive relationship between GSH/GSSG ratio and 
protein S-thiolation has been reported in many studies (3,4), and thus, S-
thiolation by a mixed-disulfide exchange reaction is generally accepted as the 
major mechanism (2). Bellomo et al. (4) reported that the increase of mixed-
disulfides occurs as a result of increased GSSG formation during menadione 
metabolism in hepatocytes. The possibility that an oxyradical-initiated 
process may play a role in the formation of S-thiolated protein cannot be 
excluded. In certain circumstances, protein S-thiolation was demonstrated to 
be initiated by reduced oxygen species (7,8). Moreover, protein S-thiolation 
in macrophages was initiated by treatment with phorbol diester, but with no 
detectable change in GSH oxidation (9). In Se-deficient hepatocytes, 
oxyradical-initiated S-thiolation possibly occurred (Table 4, Fig. 5B). 
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Because GSH Px was markedly depressed in Se-deficient hepatocytes, there 
was no detectable increase in GSSG during treatment by t-butyl 
hydroperoxide, but a significant increase of total S-thiolated CA III occurred 
at 3 min (Table 7). However, this increase of total S-thiolated CA HI in t-
butyl hydroperoxide-treated Se-deficient hepatocytes was much less than that 
detected in Se-adequate hepatocytes, suggesting that protein S-thiolation by an 
oxyradical-initiated process was less important than mixed-disulfide 
exchange. Generation of S-thiolated proteins in Se-deficient rat liver and 
heart has been reported but to a much lesser extent than in Se-adequate 
controls (35,36). For example, with t-butyl hydroperoxide infusion, there was 
only 14% of the total S-thiolation in Se-deficient rat heart as in Se-adequate 
rat heart. In perfused rat liver, a significant decrease in the formation of S-
thiolated protein was observed in Se-deficient animals during menadione 
treatment (18). 
Intracellular total GSH (GSH+GSSG) was depleted in hepatocytes 
during menadione metabolism but not in cells tieated with t-butyl 
hydroperoxide (Table 3). Menadione causes the oxidation of GSH to GSSG 
by the action of GSH Px in metabolizing H2O2, which is generated as a 
consequence of menadione redox cycling and the action of superoxide 
dismutase (37). GSSG is then reduced to GSH by GSH reductase or reacts 
with proteins to form S-thiolated proteins (4,38). Also as an electiophilic 
compound, menadione may reacts directly with GSH to generate menadione-
GSH conjugate, 1 -methyl-3-glutathionyl-1,4-naphthoquinone which is 
excreted into the medium (39). Therefore, the formation of menadione-GSH 
conjugate may partly contribute to the depletion of total GSH level. Up to 
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15% of the total intracellular GSH can be lost by this conjugation in isolated 
rat hepatocytes during menadione metabolism (39). The difference in changes 
in GSH/GSSG status over time during treatment of t-butyl hydroperoxide 
compared with menadione treatment can also partly account for difference in 
total GSH depletion. GSSG produced by GSH Px is subsequently reduced by 
glutathione reductase (4,38). However, when the rate of formation of GSSG 
exceeds that of its reduction, a transport out of cells occurs (33). GSSG 
formation during treatment with t-butyl hydroperoxide is reduced normally 
over time (Table 3). However, GSSG accumulated in hepatocytes treated with 
menadione. A 10- to 20- fold increase of GSH release was reported in 
perfused rat liver during menadione treatment (36). The inhibitory effect of 
menadione on GSH reductase activity might partly explain the accumulation 
of GSSG in hepatocytes (4). 
The pattern of S-thiolation in Se-adequate hepatocytes during treatment 
with t-butyl hydroperoxide or menadione paralleled changes in the glutathione 
status (Table 3, Fig. 5A). The S-thiolation of CA III was stimulated by 
incubation with either reagent, S-thiolation reached a maximum at 3 min of t-
butyl hydroperoxide treatment when GSH/GSSG ratio was the lowest, and 
then the dethiolation of S-thiolated CA III accompanied the reduction of 
GSSG. However, in the case of menadione treatment, the amount of S-
thiolated CA III increased gradually over time and no dethiolation happened. 
Similarly, the GSH/GSSG ratio decreased gradually and no reduction of 
GSSG occurred. The different effects of t-butyl hydroperoxide and 
menadione on protein S-thiolation was possibly caused by an inhibitory effect 
of menadione on dethiolase activity in hepatocytes, similar to the effect of 
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menadione on GSH reductase (4). Dethiolation may occur either 
spontaneously by a mixed-disulfide exchange or enzymatically by the action 
of dethiolase (6). However, in the case of menadione, which produced such a 
low GSH/GSSG ratio, S-thiolated CA m probably would not be dethiolated 
through mixed-disulfide exchange. In this situation, dethiolation catalyzed by 
dethiolase may play the more important role. It has been reported that S-
thiolated CA HI was dethiolated much more efficientiy through the action of 
dethiolase (13). 
Although CA III S-thiolation in Se-deficient hepatocytes in the presence 
of t-butyl hydroperoxide or menadione occurred to a much lesser extent than 
in Se-adequate hepatocytes, the change of CA III S-thiolation/dethiolation 
over time showed no difference between these two cells. Dethiolation 
occurred after 3 min of t-butyl hydroperoxide treatment but no dethiolation 
occurred in the presence of menadione. These results indicated that 
dethiolation works similarly in Se-adequate and Se-deficient hepatocytes. 
In conclusion, the suppression of S-thiolation of CA III in Se-deficient 
hepatocytes under oxidative stress supports the idea that hepatic protein S-
thiolation depends primarily upon mixed-disulfide exchange. 
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Figure 1. Dose-dependent GSH depletion on selenium- or selenium-adequate 
hepatocvtes bv BSO 
Hepatocytes were isolated from rats fed Se-deficient or Se-
adequate diets for 8 weeks as described in Materials and Methods. 
Different concentrations of BSO were added to cells at 4 h after 
plating, for 20 h. Total GSH represents the amount of reduced 
GSH plus 2x GSSG. 
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Table 1. Depletion of cultured rat hepatocytes GSH by different 
concentrations of BSO^ 
Se-adequate cells Se-deficient cells 
BSO^ Total GSHC % of control Total GSHC % of control 
mM nmole/mg protein nmole/mg protein 
0 42.2 ±2.97 100 35.3 ±2.30 100 
0.25 8.7 ±0.19 20.6 8.7 ±0.32 24.6 
0.5 5.6 ±0.57 13.3 4.8 ±0.06 13.6 
1.0 3.7 ±0.21 8.7 2.9 ±0.08 8.2 
2.0 2.4 ±0.40 5.6 1.9 ±0.06 5.4 
6.0 1.2 ±0.21 2.9 1.1 ±0.36 3.1 
^Hepatocytes were isolated from rats fed either Se-adequate or Se-
deficient diet for 8 weeks. Data are expressed as means ± standard deviations 
from triplicated samples. Samples were prepared as described in Materials 
and Methods. 
^Hepatocytes were treated with different concentrations of BSO for 20 
h as indicated, beginning 4 h after plating. 
^Total glutathione represents the total amount of reduced GSH plus 2x 
GSSG. 
98 
100 
G O 
*3 
ï ?  
al 
M (M S O 
0^ 
-M O 
H 
- Se-adequate 
— •© — Se-deficient 
1 0  1 5  2 0  
Exposure Time (Hr) 
Figure 2. Time-dependent GSH depletion bv BSO treatment of selenium-
deficient or selenium-adequate hepatocytes 
Hepatocytes were isolated from rats fed Se-deficient or Se-
adequate diet for 8 weeks as described in Materials and Methods. 
Different concentrations of BSO were added to cells at 4 h after 
plating for 20 h. Total GSH represents the amount of reduced 
GSH plus 2x GSSG. 
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Table 2. Depletion of cultured rat hepatocytes total GSH by BSO as a 
function of time^ 
Se-adequate cells Se-deficient cells 
%of  %of  
Time Control BSOb control Control BSO control 
Hour nmole/mg protein nmole/mg protein 
0 32.7 ±0.72 32.7 ±0.72 100 30.9 ±0.79 30.9 ±0.79 100 
5 30.2 ±0.95 12.5 ±1.73 41.3 29.4 ±0.85 12.5 ±0.96 42.4 
10 33.6 ±2.19 5.19 ±0.39 15.5 30.3 ±1.06 7.30 ±0.57 24.1 
20 42.2 ±2.97 2.36 ±0.40 5.6 35.3 ±2.30 1.90 ±0.06 5.4 
^Hepatocytes were isolated from rats fed either a Se-adequate or Se-
deficient diet for 8 weeks. Data are expressed as means ± standard deviations 
from triplicated samples. Samples were prepared as described in Materials 
and Methods. Total glutathione epresents the amount of reduced GSH plus 
2x GSSG. 
^2 mM BSO treatment began at 4 h after plating for times as indicated. 
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Table 3. Effects of t-butyl hydroperoxide and menadione on GSH in 
selenium-adequate cultured rat hepatocytes^ 
T^tâi GSH/GSSG 
Time n GSH GSSG Glutathione^ Ratio 
min nmole/mg protein 
0 4 38.0 ±3.47^ 1.39 ±0.17^ 40.8 ±3.35^ 27.9 ±4.97^ 
t-Butyl hydroperoxide (0.5 mM) 
3 4 13.9±1.39<^ 12.0±1.65d 37.9±2.36^ 1.1910.28^ 
9 4 22.9 ±1.47® 6.38 ±1.55® 36.0 ±3.99^ 3.75 ±0.88^ 
15 4 29.0 ±2.67^ 3.30 ±0.36® 35.9 ±3.19® 8.87 ±1.25® 
Menadione (0.2 mM) 
5 4 3.87 ±0.98^ 12.3 ±2.65^ 28.6 ±4.45^ 0.34 ±0.15^ 
10 4 2.63±0.55^ 11.2 ±3.41^ 25.0±6.48^ 0.26±0.11^ 
^Hepatocytes were isolated from rats fed Se-adequate diet for 8 weeks. 
They were treated with 0.5 mM t-butyl hydroperoxide or 0.2 mM menadione 
at 24 h after plating. Data are expressed as means ± standard deviations. 
^Total glutathione represents the amount of reduced GSH plus 2x 
GSSG. 
cd®f'preatments not sharing a letter aie significantly different (p<0.05). 
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Table 4. Effects of t-butyl hydroperoxide and menadione on GSH in 
selenium-deficient cultured rat hepatocytes^ 
Total GSH/GSSG 
Time n GSH GSSG Glutathione^ Ratio 
min nmole/mg protein 
0 4 32.8 ±2.61^ 1.03 ±0.07^ 34.8 ± 2.73^ 31.9 ±1.42^ 
t-Butyl hydroperoxide (0.5 mM) 
3 4 31.4±3.19C 1.08 ±0.08^ 33.6 ±3.11^ 29.1 ±4.35^ 
9 4 27.8 ±0.84^ 0.90 ±0.05^ 29.6 ±0.88'^ 31.0 ±1.46^ 
15 4 25.9 ±1.28^ 0.89 ±0.10^ 27.7 ± 1.44^ 29.4 ±2.54^ 
Menadione (0.2 mM) 
5 4 16.1 ±2.47^ 2.82 ±0.82^ 21.7 ± 1.64^ 6.26 ± 2.56^ 
10 4 12.6 ±2.81^ 2.52 ±0.22^ 17.6 ±2.44® 5.08 ±1.50^ 
^Hepatocytes were isolated from rats fed a Se-deficient diet for 8 
weeks. They were treated with 0.5 mM t-butyl hydroperoxide or 0.2 mM 
menadione at 24 h after plating. Data are expressed as means ± standard 
deviations. 
^Total glutathione represents the amount of reduced GSH plus 2x 
GSSG. 
^^®Treatments not sharing a letter are significantly different (p<0.05). 
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Table 5. Effects of t-butyl hydroperoxide and menadione on GSH in 
BSO-treated selenium-adequate cultured rat hepatocytes^ 
Total GSH/GSSG 
Time n GSH GSSG Glutathione^ Ratio 
min nmole/mg protein 
0 4 2.01 ±0.51^ 0.16±0.02^ 2.30±0.62^ 13.4 ±2.68^ 
t-Butyl hydroperoxide (0.5 mM) 
3 4 1.20 ±0.14^ 0.40 ±0.20^ 2.00 ±0.64^ 3.79 ±2.11^ 
9 4 0.77^® 0.38^ 1.53^ 
15 4 0.53® ND 0.53<^ 
Menadione (0.2 mM) 
5 4 ND 0.63 ±0.23^ 1.2710.46^ 
10 4 ND 0.31^ 0.62 ±0.13^ 
^Hepatocytes were isolated from rats fed a Se-adequate diet for 8 
weeks. They were treated with 2 mM BSO at 4 h after plating, then treated 
with 0.5 mM t-butyl hydroperoxide or 0.2 mM menadione at 20 h after BSO 
treatment. Data are expressed as means ± standard deviations. ND=Non-
detectable. 
^Total glutathione represents the amount of reduced GSH plus 2x 
GSSG. 
^^^Treatments not sharing a letter are significantly different (p<0.05). 
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Table 6. Effects of t-butyl hydroperoxide and menadione on GSH in 
BSO-treated selenium-deficient cultured rat hepatocytes^ 
Total GSH/GSSG 
Time n GSH GSSG Glutathione^ Ratio 
min nmole/mg protein 
0 4 2.24 ±0.23^ 0.13 ±0.02^ 2.39 ±0.15^ 17.0 ±4.88® 
t-Butyl hydroperoxide (0.5 mM) 
3 4 1.26±0.15^® ND 1.2610.15^® 
9 4 1.55±0.51<^ ND 1.55 ±0.5 W 
15 4 0.96 ±0.20® ND 0.96 ±0.20® 
Menadione (0.2mM) 
5 4 1.39 ±0.53^ 0.12^ 1.45 ±0.64^ 18.4® 
10 4 0.78 ±0.22^ ND 0.78 ±0.22^ 
^Hepatocytes were isolated from rats fed a Se-deficient diet for 8 
weeks. They were treated with 2 mM BSO at 4 h after plating, then treated 
with 0.5 mM t-butyl hydroperoxide or 0.2 mM menadione at 20 h after BSO 
treatment. Data are expressed as means ± standard deviations. ND=Non-
detectable. 
^Total glutathione represents the amount of reduced GSH plus 2x 
GSSG. 
^^^Treatment not sharing a letter are significantly different (p<0.05). 
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Figure 3. Effect of t-butyl hydroperoxide on selenium-deficient or selenium-
adequate hepatic intracellular GSH 
Hepatocytes were isolated from rats fed Se-deficient or Se-
adequate diet for 8 weeks as described in Materials and Methods. 
At 24 h after plating, cells were treated with 0.5 mM t-butyl 
hydroperoxide for 0, 3, 9, and 15 min, respectively. Results are the 
means of 2 samples from each of two experiments. 
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Figure 4. Effect of menadione on intracellular GSH from selenium-deficient 
or selenium-adequate rats 
Hepatocytes were isolated from rats fed Se-deficient or Se-
adequate diet for 8 weeks as described in Materials and Methods. 
At 24 h after plating, cells were treated with 0.2 mM menadione 
for 0, 5, and 10 min. Results are the means of 2 samples from each 
of two experiments. 
Figure 5. Western blotting of lEF gels in detecting the extent of S-thiolation 
of CA in in Se-adequate and Se-deficient hepatocytes treated with 
either t-butyl hydroperoxide or menadione 
S-thiolation was analyzed as described in Materials and Methods. 
One and half p.g soluble protein was applied to an lEF gel in each 
sample. (A) CA in S-thiolation in Se-adequate hepatocytes. Lanes 
a and b show the untreated hepatocytes. Lanes c to f show the 
hepatocytes treated with 0.2 mM menadione and lanes g to j from 
the cells treated with 0.5 mM t-butyl hudroperoxide. (B) CA III S-
thiolation in Se-deficient hepatocytes. Lanes a shows the untreated 
hepatocytes. Lanes b to e show the hepatocytes treated with 0.2 
mM menadione and lanes f to i from the cells treated with 0.5 mM 
t-butyl hudroperoxide. S-thiolation of CA III was stimulated by 
treating hepatocytes after 24 h in culture with 0.2 mM menadione or 
0.5 mM t-butyl hydroperoxide at 37°C for the time indicated. 
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Figure 6. Western blotting of lEF gels in detecting the extent of S-thiolation 
of CA in in BSO-treated Se-adequate and Se-deficient hepatocytes 
treated with either t-butyl hydroperoxide or menadione 
Hepatocytes were treated with 2 mM BSO at 4 h after plating, then 
treated with menadione or t-butyl hydroperoxide at 37°C for the 
time indicated at 20 h after BSO treatment. S-thiolation was 
analyzed as described in Materials and Methods. One and half |ig 
soluble protein was applied to an lEF gel in each sample. (A) CA 
in S-thiolation in Se-adequate hepatocytes. Lanes a shows the 
untreated hepatocytes. Lanes b to e show the hepatocytes treated 
with 0.2 mM menadione and lanes f to i from the cells treated with 
0.5 mM t-butyl hudroperoxide. (B) CA III S-thiolation in Se-
deficient hepatocytes. Lanes a shows the untreated hepatocytes. 
Lanes b to e show the hepatocytes treated with 0.2 mM menadione 
and lanes f to i from the cells treated with 0.5 mM t-butyl 
hudroperoxide. 
Se-ADEQUATE 
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MENADIONE t-BuOOH 
Min O 5^ 1010 VTs 
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a b  c d e f  g h i  
DTT — — + — 4- — 4- — — 
Se-DEFICIENT 
0.2 mM 0.5 mM 
MENADIONE f-BwOOH 
Min 0 5 5 10 10 3^ 9^5 
^ «##m*^<-REDUCED 
m m  * <-S%î,OlATE0 
_ FULLY 
^S-THIOLATED 
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a b c  d o f  g h i  
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Table 7. Increase of CA III S-thiolation in rat hepatocytes treated with 
either t-butyl hydroperoxide or menadione^ 
+Se -Se 
Increase in S-thiolated Increase in S-
CA ni thiolated CA III 
Time Partially- Fully- Totalb Partially-^ 
min 
o
 
o
 
o
 
CL
 
100^ 100^ 100^ 
t-Butyl Hydroperoxide (0.5 mM) 
3 186,6 ±12.3^ 134.8 ±3.5^ 172.3 ± 4.4^ 122.9 ±9.3® 
9 148.9 ±17.0® 125.0 ±5.4^ 143.0 ±15.7® 118.9± 4.7^® 
15 122.7 ±11.6^® 113.2 ±3.0® 120.5 ± 10.0^® 106.3 ± 8.9^® 
Menadione (0.2 mM) 
5 183.6 ±8.1^ 175.7 ±16.0^ 181.2 ± 6.3^ 111.2 ±5.5^® 
10 201.4 ±7.3^ 178.1 ±37.1^ 192.8 ± 11.4^ 122.5 ±6.5® 
^Hepatocytes were isolated from rats fed either a Se-adequate or Se-
deficient diet for 8 weeks. Data are expressed as means ± standai'd deviations 
from triplicated samples. Samples were prepared and analyzed as described 
in Materials and Methods. 
^Total S-thiolated CA III is equal to the sum of paitially and fully S-
thiolated CA III. 
^In Se-deficient hepatocytes there is no change in the amount of fully S-
thiolated CA III by treating with t-butyl hydroperoxide or menadione. 
^^^Treatments not sharing a letter are significantly different (p<0.05). 
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Figure 7. CA III S-thiolation in selenium-adequate or selenium-deficient 
hepatocvtes treated with t-butvl hydroperoxide 
Hepatocytes were isolated from rats fed Se-deficient or Se-
adequate diet for 8 weeks and carried out as described in Materials 
and Methods. Cells were treated with 0.5 mM t-butyl 
hydroperoxide at 24 h after plating to dishes for 0, 3, 9, and 15 
min, respectively. Total S-thiolated CA III represents the amount 
ofpartially and fully S-thiolated CA III. Treatments not sharing a 
letter are significantly different (p<0.05). 
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Figure 8. CA III S-thiolation in selenium-adequate or selenium-deficient 
hepatocvtes treated with menadione 
Hepatocytes were isolated from rats fed Se-deficient or Se-
adequate diet for 8 weeks and carried out as described in Materials 
and Methods. Cells were treated with 0.2 mM menadione at 24 h 
after plating to dishes for 0, 5, and 10 min, respectively. Total S-
thiolated CA III represents the amount of paidally and fully 
Sthiolated CA III. Treatments not sharing a letter aie significantly 
different (p<0.05). 
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ABSTRACT 
Buthionine sulfoximine (BSO) treated Se-deficient and Se-adequate rats 
were used to study the effects of intracellular GSH level and Se status on 
paraquat toxicity. The induction of CA III S-thiolation during oxidative 
stress, measured by lEF/Westem blotting, was examined. BSO, a GSH 
synthesis inhibitor, effectively depleted hepatic GSH by 70-75% in Se-
deficient and Se-adequate rats as compared with untreated controls. This 
intracellular GSH depletion potentiated paraquat toxicity in Se-deficient rats 
as seen in hepatic liver peroxidation. In contrast, enhancement of lipid 
peroxidation by BSO combined with paraquat treatment was not observed in 
Se-adequate animals. Selenium status did not change hepatic intracellular 
GSH, GSSG and the ratio of GSH to GSSG. However, in Se-deficiency, 
paraquat caused a significant decrease of hepatic GSH but this depletion was 
not observed in Se-adequate rats. These results indicates an interaction 
between Se status, intracellular GSH level, and paraquat on the rat's 
susceptibility to paraquat toxicity. The activity of plasma glutamate-pyruvate 
transaminase (GPT) was also found to be increased in Se-deficient rats treated 
with paraquat. However, paraquat caused no changes in the activity of plasma 
GPT in Se-adequate rats whether pretreated with BSO or not. In contrast, an 
inhibition of plasma GPT activity was noted in paiaquat-treated Se-deficient 
rats pretreated with BSO. CA III is a major S-thiolatable protein in male rat 
liver. S-thiolation was not induced after 8 h of the tieatment of paiaquat in 
either Se-adequate or Se-deficient rats. Paraquat neither increased GSH 
oxidation nor induced CA III S-thiolation. Therefore, an increase of 
intracellular GSSG concentration may be required to stimulate S-thiolation in 
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liver. Se-deficient rats had less total CA in, 35% less irreversibly modified 
CA in and a lesser proportion of this modified CA III (by 15%). The nature 
of this modification and the metabolic significance of such differences need 
further study. These results suggest that Se-deficiency alters CA III 
metabolism (and perhaps its expression) significantly. The lack of GSH Px, 
and therefore diminished GSH/GSSG redox cycling, suppresses protein S-
thiolation, which may be of significance to metabolic regulation during Se-
deficiency. 
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INTRODUCTION 
Protein S-thiolation is the formation of mixed-disulfide between protein 
sulfhydryls and low molecular weight thiols such as GSH, cysteine, and 
cysteamine. Because GSH is present in cells in millimolar amounts (1) and in 
much higher concentrations than cysteine or cysteamine (2,3), glutathionated 
proteins are likely to be the major form of S-thiolated proteins. Protein S-
thiolation may be a significant metabolic regulator (4). By isoelectric 
focusing analysis (lEF), glutathionated proteins can be separated from reduced 
forms of proteins because each glutathione has a net charge of -1. Recently, 
lEF has been used to study protein S-thiolation under oxidative stress (5). 
Glutathionated carbonic anhydrase III (CA III), the major S-thiolated protein 
in rat liver cytosol under oxidative stress, has two reactive sulfhydryls, and 
has been shown to be separated from fully reduced CA III on the basis of 
changes in pi from 7.0 to 6.4 and/or 6.1 (6,7), depending on the numbers of 
cysteine residues which are modified. Isoelectric focusing analysis can be 
more sensitive and have more general use in combination with 
immunoblotting. This combined method may provide a useful tool in 
studying protein S-thiolation under oxidative stress in vivo. 
Oxidative stress arises when the balance between prooxidants and 
antioxidants in a cell is disturbed in favor of the prooxidants (11). This 
condition has been implicated to underly drug toxicity, aging, and 
carcinogenesis. Many chemicals such as paiaquat, diquat, nitrofurantoin and 
the antibiotic, adriamycin, have been known to be able to generate oxidative 
stress. Paraquat (1, 1 '-dimethyl-4,4'-bipyridyl) is a broad spectium and widely 
used herbicide. Its toxicity in mammals (12,13) and accidental as well as 
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intentional poisoning in humans (14,15) have been reported. Although the 
mechanism of paraquat toxicity has not been clearly defined, its redox cycling 
properties were considered to be the major mechanism in interfering with cell 
metabolism (16-18). The cyclic one electron reduction/oxidation of paraquat 
may generate of reactive oxygen species, e.g., singlet oxygen, superoxide 
anion, hydrogen peroxide, and hydroxyl radical, and/or depletion of cellular 
reducing equivalents such as NADPH, thus, may be crucial for perturbing 
important cell processes. 
The existence of such a mechanism in vivo is supported by evidence 
that paraquat toxicity in rats is increased by exposure to pure 02 (19,20) and 
decreased by the administration of superoxide dismutase (19). Furthermore, 
paraquat toxicity is increased in rats administered diethyl maleate (21,22) or 
fed a diet deficient in selenium or vitamin E (21,23,24). Many toxic effects 
caused by paraquat have been described, such as the induction of lipid 
peroxidation (21,23), reduction of fatty acid synthesis (25), inhibition of DNA 
synthesis (26), and cytoskeletal perturbation (26). 
One consequence of oxidative stiess by agents such as paiaquat can be 
protein S-thiolation. Intracellular S-thiolated protein in paraquat-treated 
isolated perfused rat liver was increased 50% compaied with untreated rat 
liver (27). Protein S-thiolation has many consequences in cellular metabolism 
(4,28,29). For example, the activities of several enzymes in glucose 
metabolism can be modulated by protein S-thiolation. During oxidative 
stress, GSH Fx generates GSSG. An increase in cellular GSSG may stimulate 
protein S-thiolation, thereby activating enzymes which increase glucose-6-
phosphate. Glucose-6-phosphate dehydrogenase then uses glucose-6-
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phosphate to produce NADPH. GSSG is reduced to GSH by GSH reductase 
with the consumption of NADPH, The net effect of an increase in cellular 
GSSG would be to activate gluconeogenesis and glycogenolysis and to inhibit 
glycolysis and glycogen synthesis. For example, the activities of glucose-6-
phosphate dehydrogenase, glycogen phosphorylase, and fructose-1,6-
bisphosphatase are activated by disulfides, while the activities of 
phosphofructokinase, pyruvate kinase, and glycogen synthetase are inhibited 
(4,28,29). Protein S-thiolation may result from direct interactions between 
protein sulfhydryls and oxyradical species (30,31). Thus, S-thiolation may act 
in a protective role to prevent formation of other oxidized forms of sulfur that 
may result in protein degradation during oxidative stress. Protein S-thiolation 
may also prevent oxyradical species from damaging other cellular 
macromolecules. 
Selenium deficiency has been thought to increase hepatic GSH 
concentration (8,9), while depleting Se-dependent GSH peroxidase (10) which 
may prevent the formation of GSSG. If S-thiolation depends upon GSSG 
concentration, then selenium deficiency may be expected to suppress protein 
S-thiolation. If S-thiolation depends on the generation of reactive oxygen 
species to form protein thiyl reactions, then Se-deficient rats treated with 
oxidative stressors might be more susceptible to protein S-thiolation. 
Protein S-thiolation can be induced by increasing GSSG, but perhaps 
total glutadiione status also alters protein S-thiolation. Depletion of total GSH 
by agents such as BSO should block protein S-thiolation. Thus, buthionine 
sulfoximine (BSO), a GSH synthesis inhibitor, was used to deplete 
hepaticintracellular GSH in this experiment to examine its effect on protein S-
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thiolation during paraquat treatment, in conjugation with Se deficiency. 
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MATERIALS AND METHODS 
Materials 
Paraquat (1,1 '-ciimethyl-4,4'-bipyridyl), L-buthionine-S,R-sulfoxiniine 
(BSO), iodoacetamide (lAM), benzamidine, leupeptin, and 
phenylmethylenesulfonyl fluoride (PMSF) were obtained from Sigma 
Chemical Co. (St. Louis, MO). Peroxidase anti-rabbit IgG kit was from 
Vector Laboratories (Burlingame, CA). Ampholytes were from Pharmacia 
LKB (Piscataway, NJ). Gel Bond was obtained from FMC Co. (Rockland, 
CA). NetFix was from Serva Biochem Inc. (Westbury, NJ). 1,1,3,3-
tetramethoxypropane was from Aldrich Chemical Co. (Milwaukee, WI). 
Animals 
Forty-eight 4-week old male Sprague-Dawley rats from Sasco Co. 
(Omaha, NE) were fed the experimental diets for 8 weeks. They were 
randomly assigned to stainless steel grid cages and housed individually in a 
room with a 12 hr light-dark cycle. Torula yeast-based diets were prepared as 
described (32) (Table 1). The control diet contained 0.5 ppm selenium as 
Na2Se03. Animals were allowed ad libitum access to diets and distilled 
deionized water. Selenium status was determined by measuring liver 
glutathione peroxidase (GSH Px) activity (33). 
After 8 weeks, paraquat (10 mg/kg body weight) was administered 
intraperitoneally to rats 8 hr before sacrifice. Buthionine sulfoximine (4 
mmol/kg body weight) was given intraperitoneally at 1.5 h before paraquat 
treatment. Animals treated with no paraquat or BSO were injected with saline 
intraperitoneally. All sacrifices were done between 4 and 6 pm. 
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Animals were anestlietized with diethyl ether, and blood samples were 
collected from the jugular vein before opening the peritoneal cavity. 
Tetrasodium EDTA (1 mg/ml of blood) was used as an anticoagulant and 
plasma was separated by centrifugation. By the portal vein, liver was 
perfused with cold phosphate-buffered saline to remove blood. After 4 min 
perfusion, liver was removed, freeze-clamped in liquid nitrogen immediately 
and powdered, then stored at -70OC until analysis. For CA III S-thiolation 
assays, 0.5 g powdered frozen liver was homogenized with a Teflon-glass 
homogenizer in 5 ml of 20 mM HEPES (pH 7.4), containing 5 mM EDTA, 5 
mM EGTA, 0.1 mM PMSF, 1 mM Benzamidine, 4 p-g/ml leupeptine, and 50 
mM I AM. For lipid peroxidation and GSH/GSSG assays, 0.5 g of samples 
were homogenized in 5 ml of 50 mM potassium phosphate buffer (pH 7.0). 
Lipid peroxidation was determined as thiobarbituric acid-reactive substances 
(TB ARS) (34). The fluorescence of samples was detected at an excitation 
wavelength of 515 nm and an emission wavelength at 555 nm in a Fluorolog 2 
Spectrometer (Spex Industries, Inc., Metuchen, NJ). 1,1,3,3-
tetramethoxypropane was used as a TBAR standard. Glutathione and GSSG 
were assayed by HPLC as described by Reed et al (35). Glutamate-pyruvate 
transaminase (GPT) was measured on the day of blood collection by a kit 
(Sigma Chemical Co., St. Louis, MO). Liver glutathione peroxidase (GSH 
Px) activity was determined with hydrogen peroxide (H2O2) as substrate (33). 
CA in S-thiolation was measured by combining thin-gel isoelectric 
focusing analysis (5) and immunostaining (refer to Section 1). Cell extracts 
containing equal amount of proteins were applied to 0.8 mm gels which 
contained 4% acrylamide (4% T-2.6% C acrylamide ) and 2% LKB 
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ampholytes in a mixture of 5 parts preblended pH 5-8 to 1 part pH 4-6 
ampholyte. For transferring proteins to nitrocellulose membrane after 
electrofocusing, lEF gels were made on NetFix (Serva Biochemical Inc., 
Westbury, NY), a mesh backing that stabilizes the gels during separation from 
the GelBond and transfer to the Western blotting transfer chamber. Gels were 
prefocused for 10 min before sample loading and samples were focused for 50 
min at 40C at a voltage limited to 1,500 v and a limited current and power of 
2.75 mA/cm and 1.125 w/cm gel width, respectively. 
Western blotting was performed as described (36) with modifications. 
Cold 0.7% Acetic acid solution was used as transfer buffer to achieve a good 
efficiency in blotting proteins from lEF gels to nitrocellulose membrane. 
After electrofocusing, the thin-gel which was supported by NetFix was 
separated from GelBond and transfer into cold 0.7% acetic acid solution 
immediately. Gels were packed as described (36) and blotted at a constant 
voltage of 100 V for 2 h. In contrast to the well-known blotting system for 
SDS-polyacrylamide gels, proteins have a net positive charge in this acidic 
blotting buffer, thus, the output from the power supply was reversed. Ice-cold 
blotting buffer was required for efficient blotting. 
The nitrocellulose membrane was immunostained with the anti-CA III 
antiserum and the peroxidase anti-rabbit IgG kit as described (37) with some 
modifications. One-hour incubations with blocking buffer, primary antibody, 
secondary antibody, and avidin-peroxidase complex were performed at 37°C. 
For color development, 0.012% H2O2 and 0.01% 3,3'-diaminobenzidine were 
used as peroxidase substrate. Membranes were analyzed by image analysis to 
quantitate the extent of modification of CA III between Se-adequate, Se-
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deficient, and BSO-treated hepatocytes during oxidative stress. The analysis 
was done by a Zeiss SEM-IPS image analysis system (Zeiss-Kontron, IB AS 
version 2.00), and all of the integrated peak area were normalized by a 
standard curve obtained from known amount of purified CA III. 
Statistic analysis was done by either one-way or three-way 
multifactorial analysis of variance. Tests of significance of treatment was 
analyzed by Student's t-test and was considered to be at p<0.05 level. 
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RESULTS 
Rats fed a Se-deficient diet for 8 weeks had significantly less GSH Px 
activity than diose fed a Se-adequate diet (Table 2, Fig. 1 ), when H2O2 was 
used as a peroxidase substrate. The average peroxidase activity in Se-
deficient groups was only 1.5% of Se-adequate groups (3.7 vs 245 jimole 
NADPH/min-mg protein, Table 3). BSO and/or paraquat treatments had no 
effect on GSHPx activity. 
With BSO treatment, reduced GSH and GSSG levels were significantly 
decreased (Table 2, Fig. 2,3). Data showed a 75 % depletion of both GSH and 
GSSG in Se-deficient rats given 4 mmole BSO/kg body weight (ip) 9.5 h 
before sacrifice compared with the Se-deficient controls. Glutathione and 
GSSG depletion by BSO in Se-adequate rats given paraquat was about 70% 
compared with Se-adequate controls. In rats dosed with 10 mg paraquat/kg 
body weight, a significant decrease in GSH and GSSG was observed only in 
the Se-deficient groups compared with untreated controls (groups 2 and 4, but 
not 6 and 8). There was no significant effect of pai'aquat, or BSO on the ratio 
of GSH to GSSG (Table 2, Fig, 4). Selenium alone had no effect on GSH or 
GSSG (Table 2, Fig. 2-4). 
Paraquat and selenium status also interacted in effects on thiobarbituric 
acid-reactive substances (TBARS) (Table 2 and Figure 5). No change in 
TBARS was observed in Se-adequate rats 8 h after paraquat administration. 
In Se-deficient rats, TBARS was significantly increased by paraquat, 
moreover, this increase in TBARS was even greater in rats given BSO before 
paraquat (group 4). Buthionine sulfoximine alone did not affect TBARS. 
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Glutathione-pyruvate transaminase (GPT) leakage, a general index of 
liver damage, was also measured in plasma samples (Table 2, Figure 6). 
There were no significant effects of paraquat and/or BSO in Se-adequate rats. 
But, in Se-deficient rats a significant increase of plasma GPT level was 
induced by administering paraquat. Se-deficient animals treated with BSO 
and paraquat had significantly decreased plasma GPT levels. Buthionine 
sulfoximine alone did not affect plasma GPT activity. 
The effects of paraquat, BSO, and selenium status and their interaction 
were analyzed by 3-way analysis of variance (ANOVA) (Table 3, Fig. 7-12). 
Paraquat caused significant decreases of GSH, GSSG and plasma GPT, but 
significantly increased TBARS production. Paraquat did not change 
GSH/GSSG ratio and GSH Px. Se-deficiency significantly decreased GSH Px 
and increased TBARS in liver. GSH, GSSG, and GSH/GSSG ratio were less 
in Se-deficient rat liver than in Se-adequate rat liver but these differences were 
not significant. Buthionine sulfoximine depleted rat liver GSH and GSSG 
levels significantly from 27.0 to 6.6 and 0.77 to 0.17 nmol/mg protein, 
respectively. This GSH synthesis inhibitor also increased the susceptibility of 
liver to lipid peroxidation measured by TBARS. However, BSO significantly 
decreased plasma GPT. 
In previous studies, a method combining isoelectric focusing analysis 
and immunoblotting detected S-thiolation of CA III in cultured hepatocytes 
either treated with t-butyl hydroperoxide or menadione. This method has been 
applied in vivo to determine the extent of CA III S-thiolation in Se-adequate 
or Se-deficient rats under the influence of paraquat and/or BSO (Fig. 13, 
Table 4). As results indicated, no significant increase of pai tially S-thiolated 
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CA in was observed in either Se-deficient or Se-adequate rats by treating with 
paraquat, BSO, or both. Most of the CA in focused on the position as 
partially S-thiolated CA HI was not dethiolatable by DTT (data not shown). 
As data were analyzed by 3-way ANOVA, the mean percentage of 
nondethiolatable CA HI in Se-adequate rats was significantly greater than in 
Se-deficient rats (26.8% vs 23.5%) (Table 5). The amount of total CA III was 
much less in Se-deficient rats than in Se-adequate rats and the amount of 
nondethiolatable CA III was also significantly less in Se-deficient rats (Table 
4,5). CA in accounted for 3.8% and 5.1% of liver total soluble proteins in Se-
deficient and Se-adequate rats, respectively (Table 5). 
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DISCUSSION 
Paraquat, by redox cycling, generates reactive oxygen species such as 
superoxide anion, H2O2, and hydroxyl radical (16-18). The detoxification of 
H2O2 by GSH Px produces GSSG. Protein S-thiolation, which is stimulated 
by GSSG or by oxyradicals, is thus expected to be induced by paraquat. 
Selenium as an essential element for GSH Px may play an important role in 
protein S-thiolation (which may have a protective role against oxidative 
stress) and therefore, Se-deficiency may increase paraquat toxicity. Se-
deficiency inhibits GSH Px activity and thus blocks the detoxification of 
H2O2 and the generation of GSSG. As a result, during Se-deficiency, 
paraquat may generate more reactive oxygen species and also affect protein S-
thiolation if the formation of GSSG is required for protein S-thiolation. In a 
previous experiment, mixed disulfide exchange was suggested to be more 
important in CA III S-thiolation than an oxyradical initiated process in 
hepatocytes under treatment with t-butyl hydroperoxide or menadione. 
Increased GSSG paralleled S-thiolation in hepatocytes, and Se-deficient 
hepatocytes had significantly less S-thiolation in response to oxidative 
stressors. 
Results clearly indicated that paraquat toxicity was enhanced in animals 
deficient in selenium and/or pretreated with BSO, based on the index of lipid 
peroxidation, TEARS. (Table 1, Fig. 5). The depletion of liver intracellular 
GSH and GSSG by paraquat was only observed in Se-deficient rats and BSO-
pretreated Se-deficient rats (Table 1, Fig. 2,3). In cells, paraquat undergoes a 
cyclic one electron reduction/oxidation with the concomitant generation of 
superoxide anion which, thereafter, generates other reactive oxygen species 
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such as hydroxyl radical and singlet oxygen (16-18). Thus, by this redox 
cycling, paraquat is capable of causing lipid peroxidation. In isolated cells or 
subcellular fractions, paraquat induced lipid peroxidation has been reported in 
many studies (16-18). Moreover, in rat liver perfused with paraquat, ethane 
production was increased (38). But in vivo, paraquat induced lipid 
peroxidation has not been well established. There are doubts regarding lipid 
peroxidation as a mechanism of paraquat toxicity (39). In the study of Burk et 
al. (23), except in Se-deficient rats, paraquat did not increase ethane 
production. Se-deficiency also increased TBARS in paraquat-tieated animals 
(24). Selenium is an essential element for GSH Px (40), which utilizes GSH 
as a substrate to reduce endogenous or exogenous hydroperoxides thus 
preventing their breakdown to reactive oxygen species. Therefore, selenium 
has been suggested to be a direct factor in controlling lipid peroxidation (23) 
and an involvement of radical reactions in lipid peroxidation by paraquat thus 
remains a possibility. 
The depletion of GSH by paraquat has been reported in many studies 
and has generally attributed to several mechanisms (27). First, it may be due 
to the formation of S-thiolated proteins. With paraquat, the induction of 
protein S-thiolation increased significantly in rat lung (25) or liver (27). A 
second possibility is increased GSH efflux as a result of increased GSH 
oxidation. Most of the GSSG produced by the action of GSH Px was reduced 
to GSH accompanied by the use of NADPH. However, NADPH 
concentration has been reported to be depleted 50% in lung (41) and in liver 
(27) by paraquat. Once NADPH reducing equivalents aie limited, most of the 
GSSG will not be reduced to GSH and may be transported out of the liver or 
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be used to generate S-thiolated proteins. However, in the present study, 
paraquat only slightly decreased intracellular GSH in Se-adequate rats with no 
increase in GSSG generation (Table 2). Moreover, in Se-deficient rats, the 
depletion of GSH by paraquat could not explained by these two mechanisms 
because there was little GSH oxidation once GSH Px activity was inhibited. 
In fact, the depletion of GSH by paraquat was greater in Se-deficient rat liver 
(Table 2, Fig. 2). Other factors must have caused GSH depletion in Se-
deficient animals. Although no evidence has been provided for the existence 
of a GSH-paraquat conjugate, it might play a role in GSH depletion. Leakage 
of GSH caused by paraquat may be the other possibility. Lipid peroxidation is 
closely related to membrane integrity (27). 
Based on the data obtained in this study, selenium status, intracellular 
GSH level, and paraquat toxicity strongly interacted. It appeal's that, in 
general, the availability of GSH is important in preventing paraquat 
hepatotoxicity, but selenium-dependent GSH peroxidase is more essential in 
this protection. This is consistent with the observation that Se-deficiency can 
potentiate lipid peroxidation during paraquat treatment. The activity of 
plasma GPT, as an index of liver damage was enhanced by paraquat in Se-
deficient rats as compared with Se-adequate animals (Table 2, Fig. 6). In 
those Se-deficient rats without BSO pretreatment, plasma GPT activity was 
significantly increased by paraquat (32.0 U vs 22.8U). But, plasma GPT 
activity in BSO-pretreated Se-deficient rats was significantly depressed (2.8 U 
vs 22.8 U). Why does GSH depletion before paraquat administration in Se-
deficient animals decrease plasma GPT? A possible explanation is that GPT 
leakage caused by paraquat might occur much eaiiier in those BSO-pretreated 
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Se-defîcient animals than in control animals because the Se-deficient rats 
treated with BSO and paraquat suffer severe oxidative stress. The plasma 
GPT might have been quickly excreted by kidney, leaving little plasma GPT 
activity at 8 h following paraquat administration. In Se-adequate rats, the 
increase of plasma GPT activity by paraquat has been reported to be enhanced 
by pretreatment with GSH depleting agents, such as diethyl maleate (21,22). 
However, in our study, plasma GPT activity in paraquat-treated Se-adequate 
animals was not affected by BSO (Table 2). 
The lack of effect of selenium status on hepatic intracellular GSH 
concentration somewhat contradicts previous work (8,9). GSH level has been 
shown to be at a minimum when 0.1 ppm selenium was fed (42,43). Selenium 
concentration greater than 0.5 ppm (42,43) or Se-deficiency (8,9) increases 
liver GSH concentration. In the present study, Se-deficient rats under 
oxidative stress due to paraquat had less GSH than Se-adequate rats. This 
suggests that Se-deficient rats have less ability to cope with the most severe 
oxidative stress. The physiological functions of GSH adaptation in Se-
deficient animals have not been explained clearly yet. 
Burk and Hill (8) have studied GSH metabolism in Se-deficient rat 
hepatocytes and have reported that GSH synthesis and turnover are 
accelerated significantly. They reported that there was a 2 fold increase in y-
glutamylcysteine synthetase activity and a significantly greater extracellular 
total GSH (GSH+GSSG). In an earlier in vivo study, there was no difference 
in hepatic GSH concentration between Se-deficient and Se-adequate rats (44). 
The increase of GSH synthesis in Se-deficient animals was still proposed to be 
true because 2-fold greater plasma GSH was measured in Se-deficient animals 
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than in Se-adequate controls. Thus, an increase of liver GSH synthesis in Se-
deficient animals was balanced by the increased release of GSH into blood. 
Greater liver GSH in Se-deficient animals has also been found in chicken (9). 
In the present study, hepatic GSH was not affected by selenium deficiency 
(29.6 vs 28.6 nmole/mg protein). This might be due to increased efflux of 
liver GSH in Se-deficient rats compensating for increased GSH synthesis (8). 
Examination of liver y-glutamylcysteine synthetase activity and plasma GSH 
may provide evidence to answer this question. 
In this study, the effects of paraquat, BSO, and selenium and their 
interaction were also analyzed by 3-way analysis of variance (Table 3). These 
results clearly indicated that paraquat caused depletion of intracellular GSH 
and GSSG and increased liver lipid peroxidation, suggesting that paraquat 
redox cycling generated reactive oxygen species (17,39). Selenium deficiency 
enhanced susceptibility to paraquat. Lipid peroxidation determined as 
TEARS was significantly increased in animals fed a Se-deficient diet for 8 
weeks before paraquat treatment. This strong relation between selenium and 
lipid peroxidation suggests the importance of GSH Px in protecting cells from 
paraquat toxicity (22-24). However, effects of other selenoproteins cannot be 
excluded. Several new selenoproteins have been identified (45) and two of 
them, including phospholipid hydroperoxide GSH Px (46) and selenoprotein P 
(47), have been purified. Phospholipid hydroperoxide GSH Px was shown to 
be an effective enzyme in utilization of fatty acid hydroperoxides which are 
esterified in phospholipid (46). Thus, it is reasonable to expect that this 
phospholipid hydroperoxide GSH Px may also play an important role in 
preventing lipid peroxidation. 
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Depletion of intracellular GSH sensitizes many cells to toxicity and 
radiation (22,48,49). BSO, discovered in 1979 (50), is widely applied in such 
experiments due to its low toxic and high specificity. In our study, GSH 
concentration was depleted 75% by BSO and animals with such depleted GSH 
had increased lipid peroxidation. Therefore, GSH protects animals from 
paraquat toxicity. 
The induction of protein S-thiolation has been reported in many studies, 
either in perfused tissues (27,51,52) or in isolated cells (53), by treating with 
paraquat, menadione, or t-butyl hydroperoxide. Protein S-thiolation was 
strongly related to the generation of GSSG and related to the ratio of GSH to 
GSSG. S-thiolation by mixed-disulfide exchange was thus accepted as the 
major mechanism. Recently, a second mechanism was proposed also to play 
an important role in protein S-thiolation because protein S-thiolation could be 
induced under circumstances where no GSH oxidation occurs (54,55). S-
thiolation of CA III was noted in Se-deficient hepatocytes during treatment 
with t-butyl hydroperoxide with no increase of GSSG concentration (Section 
2). Although the occurrence of protein S-thiolation in Se-deficient 
hepatocytes was much less than that in Se-adequate cells, protein S-thiolation 
probably occurred partly by an oxyradical-initiated process. 
However, in this study paraquat did not stimulate CA III S-thiolation 
(Fig. 13, Table 4). These results were consistent with the level of GSSG 
which did not increase during paraquat treatment. Brigelius et al. (27) studied 
the protein S-thiolation in rat liver perfused with paiaquat and have reported 
the increase of S-thiolated proteins accompanied by the increase of GSSG 
concentration. A possible explanation is that CA III S-thiolation occurred at 
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an earlier stage after paraquat administration and then S-thiolated CA III was 
dethiolated rapidly. CA in is known to be dethiolatable (7), Perhaps the dose 
of paraquat was insufficient to alter GSSG and S-thiolation. But, paraquat did 
stimulate lipid peroxidation in Se-deficient rats, suggesting that S-thiolation is 
a sign of more severe oxidative injury than TEARS formation seems to be. 
Liver homogenates containing a seemingly partially S-thiolated CA HI 
were treated with DTT but no detectable change occurred (data not shown). 
About 20-25% of total CA in in vivo cannot be dethiolated by DTT, but this 
form of CA in focuses on lEF gels at the same position as partially S-
thiolated CA HI. The molecular structure of nondethiolatable CA III is 
unknown but it may be a sulfonated form with the same net charge. Se-
deficient rat liver had significantly less nondethiolatable CA III than Se-
adequate liver (Table 5, Fig. 13). This suggests that GSH Px activity, making 
available a greater flux of GSSG, might stimulate this modification by an 
unknown mechanism. Although total GSSG did not differ between Se-
adequate and Se-deficient rats, the capacity for GSH/GSSG cycling is 
probably reduced in Se-deficient rats. This cycling may be needed for the 
observed modification of CA III. Such a modification of CA III may 
represent a general means of regulatory protein modification, but this remains 
to be confirmed with other modifiable proteins of known activity. The 
formation of nondethiolatable CA III and its molecular nature deserve further 
study. CA in may provide further insight into the general regulation of 
proteins during oxidative stress. 
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Table 1. Composition of selenium-deficient diet^ 
Ingredient^ g/kg 
Yeast, Torula 300.0 
Sucrose 585.84 
Com Oil 50.0 
Mineral Mix, Hubbell-Mendel-WakemanC 50.0 
Vitamin Mix, AIN-76A 10.0 
DL-Methionine 3.0 
Choline chloride 1.0 
Vitamin E acetate 0.1 
Vitamin A Palmitate (500,000 U/g) 0.022 
Vitamin D3 (500,000 U/g) 0.002 
Vitamin B12 (0.1% Trituration in mannitol) 0.04 
^Selenium-adequate diet contains 0.5 ppm selenium as NaaSeOs. 
b All diet ingredients were obtained from Teklad, Madison, WI. 
c The concentration (g/kg) of each mineral in the diet was: Ca, 10.87; P, 
2.50; K, 5.98; Na, 1.57; CI, 4.76; Mg, 0.474; S, 0.227; 1,0.003; Fe, 0.118; 
and Mn, 0.56. 
Table 2. Effects of paraquat on either BSO- or selenium-treated rats^ 
GSH/GSSG 
Group BSO PQ Se GSH GSSG RATIO GSH Pxb TEAR GPTC 
nmole MDA 
nmole/mg protein U /mg protein U 
1 — — — 29.6±4.8d 0.90±0.27d 36.6 ±11.id 3.97 ±0.8^ 1.57 ± 0.43d 22.8 ± 2.3deh 
2 - + - 23.1±6.5f 0.64±0.25f 38.6+11.3d 3.94 ±2.6^ 2.60 + 0.676g 32.0±1.4f 
3 + - - 7.6 + 3.86 0.18+0.116 45.7 ±10.9d 2.35 ± 1.id 1.50 + 0.49^ 26.5 ± 5.46 
4 + + — 2.8+ 1.18 0.09±0.02g 32.3 ± 4.4d 4.33+1.8^ 4.81±1.37f 2.8 ±0.98 
5 — — + 28.6 +2.3d 0.81+0.22df 37.1 + 6.9d 226+35.66 1.27 + 0.34d 20.2 ±2.5(1 
6 — + + 26.8 + 6.2df 0.76±0.26df 37.0 ± 9.8d 255 ± 68.86 1.19+ 0.39(1 24.8±4.2d6 
7 + - + 8.5 ±2.96 0.24+0.136 41.9 ±21.3^ 271 +70.56 1.41 ± 0.63d 22.7±2.1deh 
8 + + + 8.0 + 2.06 0.18+0.076 45.9 ± 9.5(1 227 ± 46.86 1.78±0.55dg 22.1±5.8dh 
^Rats were fed either a Se-adequate (0.5 ppm) or Se-deficient diet for 8 wks. Then, 4 mmole/Kg body weight of BSO 
was administered to rats by i.p.. Paraquat, 10 mg/Kg body weight, was intraperitoneally injected to rats 1.5 h after BSO 
dosing. All of the rats were sacrificed 8 h after PQ dosing. Rats without BSO or PQ u*eatment were intraperitoneally 
injected saline as control. Data are expressed as means ± standard deviation from 6 rats except that group 2 and 4 have 5 
and 7 rats, respeactively. PQ=paraquat. 
^Glutathione peroxidase (GSH Px): One unit represents one fimole NADPH was oxidized per min per mg of protein. 
^Glutamate-pyruvate transferase (GPT): One unit represents one nmole of NADH was oxidized per min per liter 
plasma. 
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Figure 1. Hepatic GSH Px in selenium-deficient and selenium-adequate rats 
also administered paraquat and/or BSO 
Rat feeding and treatments were caiTied out as described in 
Materials and Methods. One unit of GSHPx activity represents one 
|imole of NADPH was oxidized per min per mg of protein. N=6, 
except in Se-deficienct rats given BSO (n=5) and Se-deficient rats 
given BSO+paraquat (n=7). Error bars represent one standard 
deviation. Means not sharing a letter are significantly different, 
p<0.05. 
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Figure 2. Effects of selenium. BSO. and paraquat status on hepatic GSH 
Rat feeding and treatments were carried out as described in 
Materials and Methods. N=6, except in Se-deficienct rats given 
BSO (n=5) and Se-deficient rats given BSO+paraquat (n=7). Error 
bars represent one standard deviation. Means not sharing a letter 
are significantly different, p<0.05. 
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Figure 3. Effects of selenium. BSO. and paraquat status on hepatic GSSG 
Rat feeding and treatments were carried out as described in 
Materials and Methods. N=6, except in Se-deficienct rats given 
BSO (n=5) and Se-deficient rats given BSO+paiaquat (n=7). Error 
bars represent one standard deviation. Means not sharing a letter 
are significantly different, p<0.05. 
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Figure 4. Effects of selenium. BSO. and paraquat status on hepatic 
GSH/GSSG ratio 
Rat feeding and treatments were carried out as described in 
Materials and Methods. N=6, except in Se-deficienct rats given 
BSO (n=5) and Se-deficient rats given BSO+paraquat (n=7). Error 
bars represent one standard deviation. Means not sharing a letter 
are significantly different, p<0.05. 
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Figure 5. Effects of selenium. BSO. and paraquat status on hepatic TBAR 
Rat feeding and treatments were carried out as described in 
Materials and Methods. N=6, except in Se-deficienct rats given 
BSO (n=5) and Se-deficient rats given BSO+paraquat (n=7). Error 
bars represent one standard deviation. Means not sharing a letter 
are significantly different, p<0.05. 
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Figure 6. Effects of selenium. BSO. and paraquat status on hepatic plasma 
glutamate-pvruvate transferase 
Rat feeding and treatments were carried out as described in 
Materials and Methods. One unit of GPT represents one jimole of 
NADH was oxidized per min per liter plasma. N=6, except in Se-
deficienct rats given BSO (n=5) and Se-deficient rats given 
BSO+paraquat (n=7). Error bars represent one standard deviation. 
Means not sharing a letter are significantly different, p<0,05. 
Table 3. Effects of selenium status, BSO and/or paraquat treatment male rats^ 
GSH/GSSG 
N GSH GSSG RATIO GSH Pxb TEAR GPTC 
nmole/mg protein U 
nmole MDA 
/mg protein U 
PQ-treated 25 14.7+ 11.id 0.41 ± 0.33d 38.1 ± 9.6d 118± 127d 2.69±1.66d 19.7±11.9d 
PQ-untreated 23 19.1 ±11.26 0.55 ±0.386 40.1 ± 13.3d 131±13ld 1.45 ±0.476 22.9 ± 3.76 
Se-adequate 24 18.0±10.5d 0.50±0.34d 40.4 ± 12.7d 245± 57d 1.41±0.5ld 22.4 ± 4.0d 
Se-deficient 24 15.6± 12.ld 0.45±0.38d 37.7 ± 10.2d 3.7± l.ge 2.77 ±1.626 20.2 ±12. id 
BSO-treated 24 6.6 ± 3.4d 0.17 ±0.10^ 40.8±13.2d 126± 132d 2.53±1.72d 17.5±10.5d 
BSO-untreated 24 27.0 ± 5.5^ 0.77 ±0.256 37.4 ± 9.3d 122±127d 1.66 ±0.736 24.9 ± 5.26 
^Rats were fed either a Se-adequale (0.5 ppm) or Se-deficient diet for 8 wks. Then, 4 mmole/Kg body weight of BSO 
was administered to rats by i.p.. Paraquat (PQ), 10 mg/Kg body weight, was intraperitoneally injected to rats 1.5 h after 
BSO dosing. All of the rats were sacrificed 8 h after PQ dosing. Rats without BSO or PQ treatment were intraperitoneally 
injected saline as control. Data are expressed as means ± standard deviation. 
^Glutathione peroxidase (GSH Px): One unit represents one nmole NADPH was oxidized per min per mg of protein. 
^Glutamate-pyruvate transferase (GPT): One unit represents one ^imole of NADH was oxidized per min per liter 
plasma. 
^^reatments not sharing a letter are significantly different (p<0.05). 
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Figure?. Effects of paraquat, selenium, and BSO on rat liver glutathione 
peroxidase activity (GSH Pxl 
Rat feeding and treatments were carried out as described in 
Materials and Methods. Data in each bar were calculated by 
pooling samples as shown in Table 3. One unit of GSHPx activity 
represents one fxmole of NADPH was oxidized per min per mg of 
protein. N=24, except in paraquat-treated rats (n=23) and paraquat-
untreated rats (n=25). Error bars represent one standard deviation. 
Means not sharing a letter are significantly different, p<0.05. 
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Figure 8. Effects of paraquat, selenium, and BSO on rat liver GSH 
Rat feeding and treatments were carried out as described in 
Materials and Methods. Data in each bar were calculated by 
pooling samples as shown in Table 3. N=24, except in paraquat-
treated rats (n=23) and paraquat-untreated rats (n=25). Error bars 
represent one standard deviation. Means not sharing a letter are 
significantly different, p<0.05. 
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Figure 9. Effects of paraquat, selenium, and BSO on rat liver GSSG 
Rat feeding and treatments were carried out as described in 
Materials and Methods. Data in each bar were calculated by 
pooling samples as shown in Table 3. N=24, except in paraquat-
treated rats (n=23) and paraquat-untreated rats (n=25). Error bars 
represent one standard deviation. Means not sharing a letter are 
significantly different, p<0.05. 
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Figure 10. Effects of paraquat, selenium, and BSO on rat liver GSH/GSSG 
ratio 
Rat feeding and treatments were carried out as described in 
Materials and Methods. Data in each bar were calculated by 
pooling samples as shown in Table 3. N=24, except in paraquat-
treated rats (n=23) and paraquat-untreated rats (n=25). Error bars 
represent one standard deviation. Means not sharing a letter are 
significantly different, p<0.05. 
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Figure 11. Effects of paraquat, selenium, and BSO on rat liver thiobarbituric 
acid reactive substances production (TEAR) 
Rat feeding and treatments were carried out as described in 
Materials and Methods. Data in each bar were calculated by 
pooling samples as shown in Table 3. N=24, except in paraquat-
treated rats (n=23) and paraquat-untreated rats (n=25). Error bars 
represent one standard deviation. Means not shaiing a letter are 
significantly different, p<0.05. 
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Figure 12. Effects of paraquat, selenium, and BSO on plasma glutamate-
pvruvate transferase activity (GPT1 
Rat feeding and treatments were carried out as described in 
Materials and Methods. One unit of GPT represents one jimole of 
NADH was oxidized per min per liter plasma. Data in each bar 
were calculated by pooling samples as shown in Table 3. N=24, 
except in paraquat-treated rats (n=23) and paraquat-untreated rats 
(n=25). Error bars represent one standard deviation. Means not 
sharing a letter are significantly different, p<0.05. 
Figure 13, Western blotting of lEF gels in detecting the effects of selenium 
status. BSQ and/or paraquat treatment on male rat hepatic CA m 
S-thiolation 
Treatments were performed and S-thiolation was analyzed as 
described in Materials and Methods, Equal amount of liver 
homogenate proteins from three rats, which are in the same 
treatments, were pooled together and applied to lEF gels. One |ig 
soluble protein was applied to an lEF gel in each sample. 
1 2 3 4 5 6 7 8 
«a»""»«m»«m» <-REDUCED 
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Table 4. Effects of selenium status, BSO and/or paraquat treatment on 
male rat hepatic CA III and formation of nondethiolatable 
CA 111% 
Group BSO PQ Se Total CA Illb 
Nondethiolatable CA 
III as a Percentage of 
Total CA III 
(ig/mg protein 
1 — — — 41.3 ±10.0 23.0 ±2.8 
2 — + — 40.0 ± 7.8 22.7 ±2.6 
3 + — — 35.5 ± 9.2 24.0 ± 0.2 
4 + + — 36.0 ± 6.4 24.4 ±0.4 
5 — — + 46.0 ±12.0 25.7 ±1.4 
6 — + + 58.0 ±12.0 28.1 ±3.3 
7 + — + 48.0 ±11.3 27.1 ±0.5 
8 + + + 53.0 ±13.3 26.1 ±4.0 
^Rats were fed Se-adequate or Se-deficient diet for 8 weeks before 
accepted BSO or paraquat treatment. Treatments were performed as described 
in Materials and Methods. Equal amount of liver homogenate proteins from 
three rats, which are in the same treatments, were pooled together and applied 
to lEF gels. Data are expressed as means ± standard deviations from 2 pooled 
samples. 
^Carbonic anhydrase III (CA III) was calculated based on the image 
analysis and those integrated area were normalized with standard curve that the 
actual amount of reduced CA III has been known. 
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Table 5. Effects of selenium status, BSO and/or paraquat treatment on 
male rat hepatic CÂ III and formation of nondethiolatable 
CA Ilia 
N Total CA III Nondethiolatable CA III 
jig/mg protein 
PQ-treated 25 46.7 ± 14.9C 12.0 ± 4.7c 
PQ-untreated 23 42.7±ll . ic  10.8 ± 3.2c 
Se-adequate 24 51.2±13.4C 13.8 ± 3.9c 
Se-deficient 24 38.2 ± 8.9d 9.0 ± 2.3d 
BSO-treated 24 43.1±13.3C 11.1 ±4.3^ 
BSO-untreated 24 46.3 ±13.2^ 11.6±3.8C 
^Rats were fed Se-adequate or Se-deficient diet for 8 weeks before 
accepted BSO or paraquat treatment. Treatments were performed as described 
in Materials and Methods. Equal amount of liver homogenate proteins from 
three rats, which are in the same treatments, were pooled together and applied 
to lEF gels. Data are expressed as means ± standard deviations from 2 pooled 
samples. 
^Carbonic anhydrase III (CA III) was calculated based on the image 
analysis and those integrated area were normalized with standard curve that the 
actual amount of reduced CA III has been known. 
^^treatments not sharing a letter are significantly different (p<0.05). 
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SUMMARY AND CONCLUSION 
Isoelectric focusing (lEF) combined with Western blotting was shown 
to be a valuable tool in detecting glutathionated proteins on the basis of 
changing protein net charge once protein reactive sulfhydryls react with GSH. 
This technique detected the modification of carbonic anhydrase III (CA IE) by 
S-thiolation (glutathione-protein mixed disulfide formation) when primary 
cultures of rat hepatocytes were subjected to oxidative stress. As little as 10 
ng of CA in could be clearly identified on Western blots of lEF gels. With 
this method, three S-thiolated forms of CA III could be detected in 
hepatocytes treated with 0.2 mM menadione; however, only two S-thiolated 
forms of CA III were observed in hepatocytes treated with 0,5 mM t-butyl 
hydroperoxide. S-thiolation of CA III by t-butyl hydroperoxide reached a 
maximum at 3 min and decreased to control levels by 15 min, whereas 
menadione gradually increased CA III S-thiolation. These results support the 
concepts that CA HI has two reactive sulfhydryl groups and that S-thiolation 
can occur by different mechanisms. A nonreducible CA III with the same net 
charge as partially S-thiolated CA III was also detected by this method. A 
similar CA III S-thiolation pattern was observed in female hepatocytes under 
oxidative stress, although CA HI levels in females were 15-fold less than in 
males. CA in S-thiolation was also detected in rat muscle and heart and the 
blotting pattern of S-thiolated proteins was similar to the pattern in liver. This 
method may permit molecular characterization of the regulation of numerous 
specific proteins which are modified by oxidative stress and consequent S-
thiolation in vitro and in vivo. 
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The use of Se-deficient and GSH-depleted rat hepatocytes in studying 
CA in S-thiolation during treatment with t-butyl hydroperoxide or menadione 
suggested that CA HI S-thiolation occurred primarily by mixed disulfide 
exchange and was dependent on intracellular GSH concentration. In Se-
adequate hepatocytes, 30 % of CA III is S-thiolated during treatment with 0.2 
mM menadione. In the second section, data also showed that in the presence 
of BSO, a GSH synthesis inhibitor, both Se-adequate and Se-deficient 
hepatocytes had a similar dose-dependent and time-dependent response. At 2 
mM BSO, 5%, and 6% of total intracellular GSH remained in Se-adequate and 
Se-deficient cells respectively after 20 h exposure. The concentration of BSO 
that caused 50% depletion of GSH over a 20 h exposure was estimated to be 
0.15 mM. Total intracellular GSH and the ratio of GSH to GSSG were not 
different between Se-adequate and Se-deficient hepatocytes. GSH oxidation 
was markedly depressed in Se-deficient hepatocytes during treatment with 
either 0.5 mM t-butyl hydroperoxide or 0.2 mM menadione. The pattern of 
CA in S-thiolation in Se-adequate hepatocytes was concomitant with the 
formation of GSSG. 
In the in vivo study (Section 3), BSO tieated Se-deficient and Se-
adequate rats were used to study the effects of intracellular GSH level and Se 
status on paraquat toxicity. The induction of CA III S-thiolation by paraquat, 
measured by lEF/Western blotting, was also examined in this study. BSO 
effectively depleted hepatic GSH by 70-75% in Se-deficient and Se-adequate 
rats as compared with untreated controls. This intracellular GSH depletion 
potentiated paraquat toxicity in Se-deficient rats as seen in the hepatic lipid 
peroxidation (TBARS). In contrast, the enhancement of lipid peroxidation by 
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BSO pretreatment of rats given paraquat was not observed in Se-adequate 
animals. Moreover, in Se-deficient rats, paraquat significantly decreased GSH 
but this depletion was not observed in Se-adequate rats. These results indicate 
an interaction between Se status, intracellular GSH level, and paraquat in the 
rat's susceptibility to paraquat toxicity . CA in S-thiolation was not induced 
after 8 h of treatment by paraquat in either Se-adequate or Se-deficient rats. 
Paraquat did not increase GSH oxidation and did not induce CA III S-
thiolation. The increase of intracellular GSSG concentration may be required 
to increase protein S-tiiiolation. This tends to confirm the previous result 
(section 2) that mixed-disulfide exchange is the major mechanism in forming 
S-thiolated CA HI in male rat hepatocytes. A nondethiolatable form of CA HI 
was founded to a greater extent in Se-adequate liver than in Se-deficient liver. 
This protein modification may depend on GSH/GSSG redox cycling and GSH 
Px activity. The nature and significance of such protein modification deserves 
further study. 
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APPENDIX A. RAT LIVER CARBONIC ANHYDRASE III 
PURIFICATION 
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Carbonic anhydrase III (CA HI), a major liver cytosolic protein with pi 
7.0 and molecular weight of 30 kDa, has been known to be S-thiolatable 
during treatment with GSSG. Two S-thiolated forms with pi 6.4 and 6.0 have 
been identified. Because S-thiolation can change the pi value of CA HI, a 
method involving two step Trisacryl M DEAE ion exchange chromatography 
was developed to purify this S-thiolatable protein from rat liver (Chai et al. 
Arch. Biochem. Biophys. 384,270-278. 1991). 
Frozen rat liver (4 g) was homogenized with a Teflon-glass 
homogenizer in 10 X volume (w/v) of 50 mM Tris-HCl (pH 8.0), containing 5 
mM EDTA, 5 mM EGTA, 1 mM phenylmethylsulfonyl fluoride, 1 mM 
benzamidine, and 4 fxg/ml leupeptin, and the homogenate was centrifuged at 
100,000 xg for 1 h at 40C. To prevent oxidation of the reactive sulfhydryls on 
CA in, CA in was converted to the S-thiolated form for further purification. 
The supernatant was treated with 1 mM diamide and 0.5 mM GSH at SO^C for 
20 min. After treatment the supernatant was dialyzed against 10 mM Tris-
HCl buffer, pH 8.0, overnight. The dialyzed sample was then centrifuged at 
15,000 xg for 30 min to remove insoluble proteins. 
The dialyzed sample was loaded on a Trisacryl M DEAE ion exchange 
column (2.5x45 cm) that had been equilibrated with 10 mM Tris-HCl buffer, 
pH 8.0. Elution was performed at a flow rate of 0.7 ml/min with 2 times the 
bed volume of the same buffer to wash out the unbound and loosely bound 
proteins. S-thiolated CA III was eluted with a 0-0.1 M NaCI gradient and 
fractions were analyzed by lEF to identified which fraction contained CA III. 
Those fractions containing CA III were concentrated to approximately 5 ml by 
Amicon concentrator fitted with a YM 10 membrane. This concentrated 
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fraction was dialyzed against 10 mM Tris-HCl buffer, pH 8.0, overnight. 
Then the sample was treated with 10 mM DTT at SO^C for 30 min to reduce 
S-thiolated CA HI. After reduction, the sample was loaded onto a second 
Trisacryl M DEAE column ( 1.5x45 cm) and eluted with 10 mM Tris-HCl 
buffer, pH 8.0. Eluted fractions containing reduced CA III were identified by 
lEF and concentrated by Amicon concentrator. Finally, this concentrated 
purified CA IQ was dialyzed against 10 mM Tris-HCl buffer, pH 8.0, before 
stored at -lO^C. 
The elution profile of the first step purification is shown in Panel A. 
Three groups of proteins with different binding affinity were eluted, two prior 
to the NaCl gradient and one after the gradient. Eluted fractions were 
analyzed by lEF to identify S-thiolated CA III and results are shown in Panel 
C (lanes a, b, and c). It is clear that S-thiolated CA III was eluted after the salt 
gradient. However, at this step, several contaminating proteins with pi less 
than 6.1 were also present. A second column was thus developed to further 
purify CA III. The elution profile of the second Trisacryl M DEAE ion 
exchange column is shown in Panel B. With the reduction of S-thiolated CA 
III by DTT, its pi was changed from 6.1 to 7.0. CA III binding affinity for the 
column was diminished. Thus, reduced CA III was separated from the 
contaminating proteins that had stronger affinity, lEF was used to identify 
which fractions contained reduced CA III and the result is shown in Panel C 
(lane d). It shows that reduced CA III was eluted in the second peak. The 
purity of this reduced CA III was also analyzed by SDS-polyacrylamide gels 
(Panel D) and was estimated to be greater than 97%. 
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APPENDIX B. STANDARD CURVE OF CA IE DETERMINED BY 
lEFAVESTERN BLOTTING 
Figure 1. The detection of different amounts of CA III by lEFAVestem 
blotting 
Different amounts of purified reduced CA III were applied to EEF 
gels and then blotting was performed as described in Section 1, 
Materials and Methods. 
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Figure 2. Standard curve of integrated area after image analysis from known 
amounts of purified CA HI 
Image analysis was done by a Zeiss-IPS image analysis sytem 
(Zieiss-Knotron, IBAS version 2.00). 
